<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="pmc-domain-id">3416</journal-id><journal-id journal-id-type="pmc-domain">molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430429</article-id><article-id pub-id-type="pmcid-ver">PMC12430429.1</article-id><article-id pub-id-type="pmcaid">12430429</article-id><article-id pub-id-type="pmcaiid">12430429</article-id><article-id pub-id-type="doi">10.3390/molecules30173461</article-id><article-id pub-id-type="publisher-id">molecules-30-03461</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Synthesis, Structure, DNA/BSA Binding, DNA Cleaving, Cytotoxic and SOD Mimetic Activities of Copper(II) Complexes Derived from Methoxybenzylamine Schiff Base Ligands</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1442-9951</contrib-id><name name-style="western"><surname>Lintnerov&#225;</surname><given-names initials="L">Lucia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-molecules-30-03461" ref-type="aff">1</xref><xref rid="c1-molecules-30-03461" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Herich</surname><given-names initials="P">Peter</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-molecules-30-03461" ref-type="aff">1</xref><xref rid="af2-molecules-30-03461" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Korcov&#225;</surname><given-names initials="J">Jana</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af1-molecules-30-03461" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Svitkov&#225;</surname><given-names initials="B">Barbora</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><xref rid="af3-molecules-30-03461" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3508-5265</contrib-id><name name-style="western"><surname>Jozef&#237;kov&#225;</surname><given-names initials="F">Fl&#243;ra</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-molecules-30-03461" ref-type="aff">1</xref><xref rid="af4-molecules-30-03461" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Valentov&#225;</surname><given-names initials="J">Jindra</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-molecules-30-03461" ref-type="aff">1</xref><xref rid="c1-molecules-30-03461" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Blom</surname><given-names initials="B">Burgert</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-30-03461"><label>1</label>Department of Chemical Theory of Drugs, Faculty of Pharmacy, Comenius University in Bratislava, 832 32 Bratislava, Slovakia; <email>peter.herich@stuba.sk</email> (P.H.); <email>flora.jozefikova@stuba.sk</email> (F.J.)</aff><aff id="af2-molecules-30-03461"><label>2</label>Institute of Physical Chemistry, Faculty of Chemical and Food Technology, Slovak University of Technology, 812 37 Bratislava, Slovakia</aff><aff id="af3-molecules-30-03461"><label>3</label>Cancer Research Institute, Biomedical Research Center, Slovak Academy of Sciences, 845 05 Bratislava, Slovakia; <email>barbora.svitkova@savba.sk</email></aff><aff id="af4-molecules-30-03461"><label>4</label>Institute of Inorganic Chemistry, Technology and Materials, Faculty of Chemical and Food Technology, Slovak University of Technology, 812 37 Bratislava, Slovakia</aff><author-notes><corresp id="c1-molecules-30-03461"><label>*</label>Correspondence: <email>lintnerova@fpharm.uniba.sk</email> (L.L.); <email>valentova@fpharm.uniba.sk</email> (J.V.)</corresp></author-notes><pub-date pub-type="epub"><day>22</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><volume>30</volume><issue>17</issue><issue-id pub-id-type="pmc-issue-id">496502</issue-id><elocation-id>3461</elocation-id><history><date date-type="received"><day>14</day><month>7</month><year>2025</year></date><date date-type="rev-recd"><day>08</day><month>8</month><year>2025</year></date><date date-type="accepted"><day>19</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="molecules-30-03461.pdf"/><abstract><p>Schiff base ligands prepared from salicylaldehyde and 2-, 3- and 4-methoxybenzylamine were used to prepare copper(II) complexes, characterized by spectral methods, elemental analysis and X-ray crystallography in the case of complex <bold>4a</bold> derived from 2-methoxybenzylamine. The DNA cleavage activity of the prepared complexes was exceptional, with best activities of over 95% one-strand cleavage for <bold>4c</bold> at 3 mM and full double-strand cleavage for complex <bold>4a</bold> at 5 mM. Absorption titration studies with ct-DNA revealed good binding constants (at 10<sup>5</sup> M<sup>&#8722;1</sup>) with a decrease of up to 56% light absorption. Meanwhile, the EB&#8211;DNA displacement method and viscosity studies revealed groove binding as a possible binding mode. For BSA binding studies, all three complexes showed K<sub>BSA</sub> values in the optimal range for reversible BSA binding (10<sup>4</sup> M<sup>&#8722;1</sup>). The copper(II) complexes showed significant cytotoxic effects (67&#8211;96% at 1 mM) in mitochondrial activity monitoring assays. Cytotoxicity was confirmed against cancer cell lines (A549 and HepG2) and HEL cells. The complexes <bold>4a</bold> and <bold>4c</bold> exhibited high activity against HepG2 cancer cells (IC50 &lt; 22 &#956;M), comparable to cisplatin. The radical scavenging activity was determined by the INT method with the best IC50 for <bold>4c</bold> (189 &#177; 11 &#956;M). Overall, complexes <bold>4a</bold> and <bold>4c</bold> with a methoxy group in the <italic toggle="yes">ortho</italic> and <italic toggle="yes">para</italic> positions show high potential in most determined activities, but mainly as DNA cleavers and as cytotoxic agents with selectivity against HepG2 cells.</p></abstract><kwd-group><kwd>copper(II) complexes</kwd><kwd>DNA binding</kwd><kwd>BSA binding</kwd><kwd>DNA cleavage</kwd><kwd>cytotoxicity</kwd><kwd>SOD mimetics</kwd><kwd>Schiff bases</kwd></kwd-group><funding-group><award-group><funding-source>Ministry of Education, Science, Research and Sport of the Slovak Republic within the Research and Development Operational Program</funding-source><award-id>ITMS 26240220084</award-id></award-group><award-group><funding-source>European Regional Development Fund</funding-source></award-group><award-group><funding-source>Ministry of Education, Science, Research and Sport of the Slovak Republic</funding-source><funding-source>VEGA</funding-source><award-id>1/0661/24</award-id><award-id>1/0175/23</award-id><award-id>1/0686/23</award-id></award-group><award-group><funding-source>Slovak Research and Development Agency</funding-source><funding-source>APVV</funding-source><award-id>19-0087</award-id><award-id>20-0213</award-id><award-id>23-0349</award-id></award-group><funding-statement>This work has been supported by the Ministry of Education, Science, Research and Sport of the Slovak Republic within the Research and Development Operational Program for the project &#8220;University Science Park of STU Bratislava&#8221;, ITMS 26240220084, co-funded by the European Regional Development Fund; Ministry of Education, Science, Research and Sport of the Slovak Republic by VEGA grant No. 1/0661/24, VEGA grant No. 1/0175/23 VEGA grant No. 1/0686/23 and Slovak Research and Development Agency by APVV grant 19-0087, APVV grant 20-0213 and APVV grant 23-0349.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-30-03461"><title>1. Introduction</title><p>The binding ability of metal complexes to DNA is crucial for the development of new metal-based chemotherapeutics and/or cytotoxic agents. Binding on its own can affect the proliferation of cells; this has been shown with platinum-based anticancer drugs. Alternatives based on copper (but also other transition metals such as nickel, manganese, zinc, iron and others) have been studied excessively because of their lower toxicity, and biocompatibility, but also their broader variety of activities due to their important role in many biological systems such as metalloenzymes. Specifically, copper possesses altered metabolism in cancer cells compared to normal cells, and it can also be found in higher amounts in cancer cells. The cancer cell might therefore be a selective target for copper-based drugs [<xref rid="B1-molecules-30-03461" ref-type="bibr">1</xref>,<xref rid="B2-molecules-30-03461" ref-type="bibr">2</xref>,<xref rid="B3-molecules-30-03461" ref-type="bibr">3</xref>]. The mechanism of action of copper in cancer cells is not fully clear, but studies from over the past several years have suggested several pathways, such as angiogenesis, inhibition of proteasome activity, modulation of ROS levels in cells or apoptosis induction targeting caspases or DNA damage [<xref rid="B4-molecules-30-03461" ref-type="bibr">4</xref>].</p><p>The anticancer mechanism of action of copper(II) complexes includes binding to DNA mostly with noncovalent interactions (various types of intercalations, major or minor groove binding or electrostatic interactions with the phosphate/sugar backbone of DNA) compared to cisplatin and its derivatives binding via covalent bonds. Additionally, the binding is also linked to oxidative cleavage induced by reactive oxygen species (ROS) generation or hydrolytic cleavage of DNA. Due to their DNA binding and cleaving properties, copper complexes are suitable antitumor agents but can also serve as DNA markers and promoters and DNA foot-printing agents [<xref rid="B5-molecules-30-03461" ref-type="bibr">5</xref>,<xref rid="B6-molecules-30-03461" ref-type="bibr">6</xref>,<xref rid="B7-molecules-30-03461" ref-type="bibr">7</xref>,<xref rid="B8-molecules-30-03461" ref-type="bibr">8</xref>].</p><p>Structural properties such as the ligand shape, size and structure and coordination geometry are key factors for the strength of DNA binding. The planar shape of ligands is especially important since it allows deeper insertion into the DNA double helix for stronger binding. The binding of the complex to DNA leads in many cases to deformation of the DNA structure, making cleavage possible, but also to DNA sequence modification. The result may be inhibition of protein synthesis, mitochondrial activity [<xref rid="B9-molecules-30-03461" ref-type="bibr">9</xref>] or cell proliferation. Copper-based antineoplastic drugs function as chemical nucleases that can oxidize nucleic bases or deoxyribose rings and hydrolyze phosphate esters [<xref rid="B10-molecules-30-03461" ref-type="bibr">10</xref>].</p><p>Schiff bases derived from aromatic aldehydes with an electron-rich <italic toggle="yes">ortho</italic> substitution such as salicylaldehyde and its derivatives, <italic toggle="yes">N</italic>-substituted 2-aminobenzaldehydes or 3-hydroxy-naphthalene-2-carbaldehyde and its derivatives, etc., also provide suitable chelating binding for copper(II) and other metals. They can be modified easily by choosing different aldehyde/amine partners in the condensation reaction and metal center allowing fine-tuning of the biological properties of the ligands and complexes [<xref rid="B3-molecules-30-03461" ref-type="bibr">3</xref>,<xref rid="B11-molecules-30-03461" ref-type="bibr">11</xref>,<xref rid="B12-molecules-30-03461" ref-type="bibr">12</xref>].</p><p>Schiff base metal complexes have been the subject of an enormous number of studies. Due to the relatively simple synthesis and metal-binding capabilities of Schiff bases, their complexes have garnered significant attention for their unique structural, biological and chemical properties. The conjugation of the C=N bond with aromatic systems or other double bonds allows for preparation of complexes with more predictable, partially planar coordination geometry, which is useful in drug design. The biological activities of Schiff base copper(II) complexes range from antibacterial, antifungal, antiradical, anticancer, antioxidant, antidiabetic properties and enzyme inhibition [<xref rid="B12-molecules-30-03461" ref-type="bibr">12</xref>,<xref rid="B13-molecules-30-03461" ref-type="bibr">13</xref>,<xref rid="B14-molecules-30-03461" ref-type="bibr">14</xref>,<xref rid="B15-molecules-30-03461" ref-type="bibr">15</xref>]. Their anticancer activities are mainly based on DNA binding and cleaving properties [<xref rid="B6-molecules-30-03461" ref-type="bibr">6</xref>,<xref rid="B11-molecules-30-03461" ref-type="bibr">11</xref>,<xref rid="B16-molecules-30-03461" ref-type="bibr">16</xref>,<xref rid="B17-molecules-30-03461" ref-type="bibr">17</xref>].</p><p>Copper complexes can undergo a fast oxidation state change between +II and +I and back by reacting with free radicals as superoxide dismutase (SOD) mimetics but they also can generate radicals (ROS) by releasing or accepting one electron. Both effects can be used in cancer therapy, either as a prevention of radical formation or as cytotoxic agents within cancer cells capable of gathering greater amounts of copper within them [<xref rid="B18-molecules-30-03461" ref-type="bibr">18</xref>,<xref rid="B19-molecules-30-03461" ref-type="bibr">19</xref>,<xref rid="B20-molecules-30-03461" ref-type="bibr">20</xref>,<xref rid="B21-molecules-30-03461" ref-type="bibr">21</xref>].</p><p>SOD mimetics are metal complexes able to turn superoxide (O<sub>2</sub><sup>&#8722;</sup>) by oxidation to oxygen (O<sub>2</sub>) and by reduction to the peroxide anion (O<sub>2</sub><sup>&#8722;2</sup>) while the redox active metal center such as Cu or Mn undergoes a change in oxidative state (II/I or III/II). The main application of SOD mimetics is their ability to absorb or release one electron, with respect to scavenge radicals or reactive oxygen species (ROS) [<xref rid="B22-molecules-30-03461" ref-type="bibr">22</xref>,<xref rid="B23-molecules-30-03461" ref-type="bibr">23</xref>,<xref rid="B24-molecules-30-03461" ref-type="bibr">24</xref>,<xref rid="B25-molecules-30-03461" ref-type="bibr">25</xref>]. ROS form naturally in the organism, mainly in mitochondria during metabolism, and their main role is in immunity and defense processes against pathogens. Their overproduction as a result of external sources, infections, increased production of uric acid, autooxidation of thiols, hyperglycemia, etc., can lead to pathological states and the development of major diseases such as cancer, atherosclerosis, stroke, asthma, heart attacks, retina damage, diabetes mellitus, etc. [<xref rid="B26-molecules-30-03461" ref-type="bibr">26</xref>,<xref rid="B27-molecules-30-03461" ref-type="bibr">27</xref>].</p><p>In this study, a series of Schiff base ligands derived from 2-, 3- and 4-methoxybenzylamines and salicylaldehyde were prepared and used in the synthesis of stereoisomeric ligand copper(II) complexes. This study is dedicated to the regio-isomerism of the methoxy group on the benzylamine moiety of the ligand molecule and its effect on the anticancer activities of the complexes. For this purpose, DNA binding and DNA cleaving assays, resazurin cell viability and tumor cell cytotoxicity MTT assays were performed. A bovine serum albumin (BSA) binding assay of the prepared complexes was performed to determine potential drug delivery to a solid tumor; alternatively, their SOD mimetic activities were studied using the INT radical scavenging method.</p></sec><sec sec-type="results" id="sec2-molecules-30-03461"><title>2. Results and Discussion</title><sec id="sec2dot1-molecules-30-03461"><title>2.1. Synthesis</title><p>The synthesis of Schiff bases <bold>3a</bold>&#8211;<bold>c</bold> started from salicylaldehyde (<bold>1</bold>) and 2-,3- and 4-methoxybenzylamine (<bold>2a</bold>&#8211;<bold>c</bold>). The procedures were performed analogously. The reaction mixture was refluxed in dry methanol for 1&#8211;2 h (<xref rid="molecules-30-03461-sch001" ref-type="fig">Scheme 1</xref>). The progress of the reaction could be observed by a change in color to yellow and TLC analysis. Schiff base products were isolated by evaporation and washed with diethyl ether as yellow oils and kept under anhydrous conditions.</p><p>The complexes of Schiff bases <bold>3a</bold>&#8211;<bold>c</bold> were prepared in methanol using copper(II) chloride, a copper(II) compound soluble in methanol without the need for heating. We wanted to avoid heating in this step to reduce any chance of decomposition of <bold>3a</bold>&#8211;<bold>c</bold>. Complexes <bold>4a</bold>&#8211;<bold>c</bold> were isolated as dark green powders (<bold>4b</bold> and <bold>4c</bold>) or fine dark green crystals (<bold>4a</bold>). Complex <bold>4b</bold> had a less usual ligand/copper ratio (2:1), which was discovered by elemental analysis and confirmed by MS studies (<xref rid="app1-molecules-30-03461" ref-type="app">Supplementary Data</xref>); the other two had the expected 2 : 2 ratios confirmed by X-ray analysis for <bold>4a</bold>. We expected <bold>4c</bold> to have an analogous structure.</p></sec><sec id="sec2dot2-molecules-30-03461"><title>2.2. X-Ray Structure of Complex <italic toggle="yes"><bold>4a</bold></italic></title><p>Complex <bold>4a</bold> crystallized in the monoclinic P2<sub>1</sub>/c space groups (No. 14) as two independent molecules (<xref rid="molecules-30-03461-f001" ref-type="fig">Figure 1</xref> and <xref rid="app1-molecules-30-03461" ref-type="app">Figure S1-1</xref>). In the cell unit, there are 14 molecules (<xref rid="app1-molecules-30-03461" ref-type="app">Figure S1-2</xref>). Complex <bold>4a</bold> consists of two Schiff base ligands and chloro ligands bonded over central atoms. The complex is created from dimeric molecules with disordered square-planar arrangement around the central atoms. Each copper center atom (Cu1/Cu1*) binds by a six-membered chelate ring to one Schiff base ligand (O1,N1) and also has a bond with phenolic oxygen O1* on the second Schiff base molecule. This coordination mode forms the four-membered ring at the center. The fourth coordination bond is with the chloro ligand. The distance of the central Cu1 atom from the plane given by the O1*O1N1 atoms is 0.409(2) &#197; and distance of Cl1 atom from same plan is 1.818(3) &#197;. The second molecule has a similar distance of the central Cu2 atom from the plane given by the O3*O3N2 atoms; this distance is 0.422(2) &#197; and the distance of the Cl2 atom from the same plane is 1.879(3) &#197;. The crystallographic data for complex <bold>4a</bold> are summarized in <xref rid="molecules-30-03461-t001" ref-type="table">Table 1</xref>. Selected bond lengths and angles are listed in <xref rid="molecules-30-03461-t002" ref-type="table">Table 2</xref>.</p><p>The stacking of molecules in crystal structure of complex <bold>4a</bold> is caused by a system of intermolecular hydrogen bonds and interactions (<xref rid="app1-molecules-30-03461" ref-type="app">Figure S1-3, Table S1-1</xref>).</p></sec><sec id="sec2dot3-molecules-30-03461"><title>2.3. EPR Studies</title><p>At 300 K, the EPR spectrum of dinuclear complex <bold>4a</bold> shows a very broad complex signal as the result of exchange/dipole interaction between unpaired copper electrons (<xref rid="molecules-30-03461-f002" ref-type="fig">Figure 2</xref>). Small, almost invisible teeth at approximately 300 mT are probably an axial spectrum component as the result of non-perfect spin&#8211;spin coupling (spin defect). This could be the result of the copper&#8211;copper distance or non-optimal geometry. At 77 K, a standard axial copper spectrum with four-line parallel component hyperfine splitting from the copper nucleus is observed, and the broad signal dominating at higher temperatures disappeared at 77 K. This suggests antiferromagnetic coupling between two copper atoms, an exchange-broadened spectrum at room temperature and the formation of an EPR silent singlet state at low temperatures. The observation of axial EPR spectra at 77 K, as well as small teeth in the spectrum at 300 K, confirms non-perfect spin&#8211;spin coupling.</p><p>As expected, derivative <bold>4b</bold> with only one copper atom in the molecule possesses a standard axial copper spectrum signal with unresolved hyperfine structure at both at room temperature and 77 K. There is no indication of any spin&#8211;spin interaction as proof of a mononuclear complex.</p><p>At 300 K, the EPR spectrum of complex <bold>4c</bold> shows a very broad complex signal with multiple signals. This is the result of the exchange reaction between unpaired copper electrons and ZFS (zero field splitting). A sharp signal at about 300 mT is probably an axial spectrum component and is more visible than that observed for the <bold>4a</bold> sample. Probably the interaction between copper atoms is slightly weaker than in the case of <bold>4a</bold>. At 77 K, a standard axial copper spectrum with four-line parallel component hyperfine splitting from the copper nucleus is observed, and the broad signal dominating at higher temperatures disappeared at 77 K. This suggests antiferromagnetic coupling between two copper atoms, as expected, similar to <bold>4a</bold>. Based on the EPR results, we can conclude that complex <bold>4c</bold> contains two paramagnetic copper atoms that can exist in an antiferromagnetic coupling.</p></sec><sec id="sec2dot4-molecules-30-03461"><title>2.4. DNA Interaction Studies</title><p>Many Schiff base copper complexes exert their anticancer activity by binding with DNA, thereby altering DNA replication and inhibiting the growth of tumor cells [<xref rid="B10-molecules-30-03461" ref-type="bibr">10</xref>,<xref rid="B28-molecules-30-03461" ref-type="bibr">28</xref>,<xref rid="B29-molecules-30-03461" ref-type="bibr">29</xref>]. The diversity of the structure of metal complexes, different geometries, coordination numbers and redox potential influence the interaction with DNA, using various binding modes [<xref rid="B30-molecules-30-03461" ref-type="bibr">30</xref>].</p><p>Copper complexes can interact with DNA via covalent and noncovalent interactions. The covalent binding mode involves the coordination of Cu<sup>+2</sup> ions with nitrogen (N7) donor atoms of guanine and adenine or phosphate groups in the DNA backbone [<xref rid="B10-molecules-30-03461" ref-type="bibr">10</xref>].</p><p>The predominately noncovalent binding mode between copper complexes and DNA includes &#960;-&#960; stacking interactions during intercalation, van der Waals interactions or hydrogen bonding associated with groove binding and electrostatic interactions [<xref rid="B5-molecules-30-03461" ref-type="bibr">5</xref>]. Interactions of the prepared complexes <bold>4a</bold>&#8211;<bold>c</bold> with calf thymus DNA were evaluated using UV&#8211;Vis absorption titrations and fluorescence emission with the ethidium bromide (EB) displacement method.</p><sec id="sec2dot4dot1-molecules-30-03461"><title>2.4.1. DNA Bnding Study by Absorption Titration</title><p>UV&#8211;Vis spectroscopic titration is routinely used to study the interaction of metal complexes with DNA and to distinguish possible binding modes. The DNA&#8211;complex interaction can be studied by comparison of UV&#8211;Vis absorption spectra of the free complex and the DNA&#8211;complex, which are usually different. Binding of the compound with DNA through intercalation usually results in hypochromism. In the case of electrostatic attraction between a compound and DNA, a hyperchromic effect appears [<xref rid="B31-molecules-30-03461" ref-type="bibr">31</xref>].</p><p>The absorption spectra of complexes <bold>4a</bold>&#8211;<bold>c</bold> (1 &#215; 10<sup>&#8722;4</sup> M<sup>&#8722;1</sup>) were recorded in the presence of increasing amounts of ct-DNA. Intraligand absorption bands with &#955;<sub>max</sub> in the region 350 &#8211;380 nm were used to monitor the interaction of compounds with ct-DNA. The intraligand absorption value was chosen as &#955;<sub>max</sub> = 258 nm, so the absorbance of DNA would not interfere. The UV&#8211;Vis spectrum affected by DNA addition is shown for complexes <bold>4a</bold> in <xref rid="molecules-30-03461-f003" ref-type="fig">Figure 3</xref>, and the UV&#8211;Vis spectra of other compounds are provided in the <xref rid="app1-molecules-30-03461" ref-type="app">Supplementary Materials (Figure S3-1)</xref>. In the UV spectra of <bold>4a</bold>&#8211;<bold>c</bold>, the intraligand absorption band of complexes (&#955;<sub>max</sub> = 370 nm) exhibited hypochromism of 32, 26 and 28%, respectively. However, the gradual addition of ct-DNA to the solution of complexes did not cause a considerable shift in the absorption wavelengths. The spectral absorption characteristics of the studied complexes are shown in <xref rid="molecules-30-03461-t003" ref-type="table">Table 3</xref>.</p><p>The DNA binding constants (K<italic toggle="yes"><sub>b</sub></italic>) of the complexes were determined by the Wolfe&#8211;Shimer equation (Equation (1)) and the respective plots (<xref rid="molecules-30-03461-f003" ref-type="fig">Figure 3</xref> and <xref rid="app1-molecules-30-03461" ref-type="app">Figure S3-1</xref>). The K<italic toggle="yes"><sub>b</sub></italic> constants are of the order of 10<sup>5</sup>, suggesting strong binding of the complexes to DNA. All three complexes showed significant interaction with DNA (K<italic toggle="yes"><sub>b</sub></italic> = 1.4&#8211;3.2 &#215; 10<sup>5</sup>).</p><p>The binding constant values of <bold>4a</bold>&#8211;<bold>c</bold> are comparable to copper(II) Schiff base complexes derived from salicylaldehyde and various alpha amino acids with K<sub>b</sub> in the 10<sup>&#8722;3</sup> to 10<sup>&#8722;4</sup> M<sup>&#8722;1</sup> range [<xref rid="B32-molecules-30-03461" ref-type="bibr">32</xref>,<xref rid="B33-molecules-30-03461" ref-type="bibr">33</xref>] or other benzylamine derivatives with K<sub>b</sub> in the 10<sup>&#8722;5</sup> to 10<sup>&#8722;6</sup> M<sup>&#8722;1</sup> range [<xref rid="B34-molecules-30-03461" ref-type="bibr">34</xref>]. This reflects the similar structure and planarity of the ligands (<xref rid="molecules-30-03461-f004" ref-type="fig">Figure 4</xref>). The conjugation effect of the imine double bond with the aromatic ring in Schiff bases and additional aromatic features in the ligand molecules creates a planar structural moiety that is beneficial for binding to DNA as intercalators or groove binders. The planarity of ligands could support the intercalation or partial intercalation binding mode of the tested complexes; the K<italic toggle="yes"><sub>b</sub></italic> constant of complexes <bold>4a</bold>&#8211;<bold>c</bold> is close to that of the classical intercalator EB (K<italic toggle="yes"><sub>b</sub></italic> = 1.23 &#215; 10<sup>5&#8722;</sup>) [<xref rid="B35-molecules-30-03461" ref-type="bibr">35</xref>]. It seems that the position of the substituent on the benzene ring in the ligand can influence the interaction with DNA. Based on the binding strength to DNA, the prepared complexes can be arranged as <bold>4c</bold> &gt; <bold>4a</bold> &#8776; <bold>4b</bold>, and the strongest effect is connected to the complex with the <italic toggle="yes">para</italic>-substituted benzene ring.</p><p>In addition to the possible intercalative mode, the metal complexes could bind to the minor groove of DNA by van der Waals interaction and hydrogen bonding [<xref rid="B36-molecules-30-03461" ref-type="bibr">36</xref>]. However, the exact binding mode of complexes into DNA cannot be determined only by absorption titration studies, so further measurements are necessary to confirm the results obtained [<xref rid="B31-molecules-30-03461" ref-type="bibr">31</xref>].</p></sec><sec id="sec2dot4dot2-molecules-30-03461"><title>2.4.2. Competitive Studies with EB&#8211;DNA</title><p>Competitive-binding experiments using the ethidium bromide (EB) displacement method from DNA may provide another confirmation of the binding affinity of the complexes. EB is a well-known DNA intercalator able to form an EB&#8211;DNA adduct by its insertion between adjacent DNA base pairs. The EB&#8211;DNA adduct is distinguished by an intense fluorescence emission band at 615 nm after excitation at 540 nm. Introducing a compound with DNA affinity leads to emission intensity decrease of the EB&#8211;DNA adduct as a result of the competition between the measured compound and EB for the binding sites within DNA.</p><p>The fluorescence emission spectra of our studied complexes <bold>4a</bold>&#8211;<bold>c</bold> are shown in <xref rid="molecules-30-03461-f005" ref-type="fig">Figure 5</xref>A and <xref rid="app1-molecules-30-03461" ref-type="app">Figure S3-2</xref>. The subsequent concentration increase of complexes led to a moderate decrease in the emission intensity band of the EB&#8211;DNA adduct. The maximum fluorescence quenching reached 40&#8211;45% of the initial EB&#8211;DNA product (<xref rid="molecules-30-03461-f005" ref-type="fig">Figure 5</xref>B, <xref rid="molecules-30-03461-t004" ref-type="table">Table 4</xref>).</p><p>The quenching of EB&#8211;DNA fluorescence is in good agreement with the linear Stern&#8211;Volmer equation (Equations (2)&#8211;(4)) and the corresponding Stern&#8211;Volmer plots (<xref rid="molecules-30-03461-f005" ref-type="fig">Figure 5</xref>A and <xref rid="app1-molecules-30-03461" ref-type="app">Figure S3-2</xref>) illustrate evidence of the interaction of tested complexes with DNA. The calculated <italic toggle="yes">K<sub>sv</sub></italic> constant (3.61&#8211;4.58 &#215; 10<sup>3</sup>) confirmed the moderate activity of complexes for EB&#8211;DNA fluorescence quenching and is comparable to other copper complexes with Schiff base ligands derived from salicylaldehyde and various amino acids [<xref rid="B32-molecules-30-03461" ref-type="bibr">32</xref>,<xref rid="B37-molecules-30-03461" ref-type="bibr">37</xref>].</p><p>According to the values of <italic toggle="yes">K<sub>sv</sub></italic> (<xref rid="molecules-30-03461-t004" ref-type="table">Table 4</xref>), the EB displacement ability of the studied Schiff base complexes was mutually comparable; however, the best effect was achieved in the complex containing the methoxy substituent in the <italic toggle="yes">ortho</italic> position (<bold>4a</bold>). Furthermore, the calculated values of the quenching rate constant <italic toggle="yes">k</italic><sub>q</sub> were higher than the value of 10<sup>10</sup> M<sup>&#8722;1</sup> s<sup>&#8722;1</sup>, indicating a static quenching mechanism that leads to the formation of a new adduct, i.e., between DNA and the complex [<xref rid="B38-molecules-30-03461" ref-type="bibr">38</xref>].</p><p>Comparing the results obtained by both DNA binding methods reveals no clear common features among the prepared complexes, except for <bold>4b</bold> showing the lowest K<italic toggle="yes"><sub>b</sub></italic> and K<italic toggle="yes"><sub>sv</sub></italic>. The somewhat similar activity in EB&#8211;DNA displacement of complexes <bold>4a</bold>&#8211;<bold>c</bold> suggests a similar mode of action (intercalation, DNA groove binding or both). The competition between EB and the complexes suggests intercalation is low, based on the weak emission reduction [<xref rid="B10-molecules-30-03461" ref-type="bibr">10</xref>]. This means that EB displacement occurs only partially, which is similar to some non-intercalating groove binders [<xref rid="B39-molecules-30-03461" ref-type="bibr">39</xref>].</p></sec><sec id="sec2dot4dot3-molecules-30-03461"><title>2.4.3. Viscosity Measurements</title><p>To further verify the interaction mode of metal complexes with ct-DNA, viscosity measurements of DNA solutions in the presence of increasing concentrations of the complexes were caried out.</p><p>Intercalation binding manifested by insertion of the compound molecule between the base pairs of DNA, causing separation between base pairs at the intercalation site to some degree and an increase in helix length. As a result, the viscosity increased. Other modes of interaction, such as groove binding and electrostatic interactions can bend or deform the DNA helix, shortening its length. This may cause a decrease in DNA viscosity [<xref rid="B31-molecules-30-03461" ref-type="bibr">31</xref>].</p><p>The effect of adding test compounds <bold>4a</bold>&#8211;<bold>c</bold> on the relative specific viscosity of DNA is shown in <xref rid="molecules-30-03461-f006" ref-type="fig">Figure 6</xref>. There was an insignificant change in the viscosity of DNA. As can be seen in the graph, the viscosity of the DNA solution increased only slightly with increasing amounts of complexes <bold>4a</bold>&#8211;<bold>c</bold>. Thus, the results indicated that the binding mode of the complexes may be predominantly groove binding. A similar effect on the viscosity of DNA was found in the other copper(II) complexes derived from an asymmetric bidentate Schiff base. Their groove binding mode was consistent with molecular docking results [<xref rid="B40-molecules-30-03461" ref-type="bibr">40</xref>].</p></sec></sec><sec id="sec2dot5-molecules-30-03461"><title>2.5. DNA Cleavage</title><p>The ability of metal complexes to bind and cleave DNA has been observed for many copper complexes. The cleavage ability of copper complexes can be determined by the standard gel electrophoresis method [<xref rid="B41-molecules-30-03461" ref-type="bibr">41</xref>] and cleavage can occur through multiple pathways. One of them is the hydrolytic mechanism, but in situ hydroxyl radical formation or oxidative cleavage assisted by a redox-active copper center is also possible [<xref rid="B42-molecules-30-03461" ref-type="bibr">42</xref>,<xref rid="B43-molecules-30-03461" ref-type="bibr">43</xref>,<xref rid="B44-molecules-30-03461" ref-type="bibr">44</xref>,<xref rid="B45-molecules-30-03461" ref-type="bibr">45</xref>]. We expected the Cu(II) complexes, exhibiting DNA binding affinity and efficient DNA cleavage, to arrest the cell cycle progression of cancer cells and further promote the apoptotic mode of cell death [<xref rid="B46-molecules-30-03461" ref-type="bibr">46</xref>,<xref rid="B47-molecules-30-03461" ref-type="bibr">47</xref>].</p><p>The gel electrophoresis separation of the supercoiled DNA plasmid pBR322 induced by prepared copper(II) complexes is shown in <xref rid="molecules-30-03461-f007" ref-type="fig">Figure 7</xref>. One copper(II) complex <bold>4a</bold> completely cleaved plasmid supercoiled DNA into a linear form (Form III), thus demonstrating its highest DNAse activity at a concentration of 5 mM. The other copper(II) complexes (<bold>4b</bold>&#8211;<bold>c</bold>) cleaved the plasmid supercoiled form of DNA (Form I) to an open-circular, partly cleaved form (Form II) and showed weaker DNAse activity. The cleavage activity of <bold>4a</bold> and <bold>4c</bold> increased remarkably with increasing concentration.</p><p>The DNA cleaving activities were also quantified using the &#8220;geneQUANT software&#8221; (Cleaver Scientific, UK). Data are expressed as percentage (%) expression of the amount of pDNA that has passed through the effect of the nuclease activity of the copper complex from the uncleaved supercoiled Form I to the cleaved Form II (open-circular pDNA) or Form III (linear pDNA) (<xref rid="molecules-30-03461-t005" ref-type="table">Table 5</xref>). Each applied sample had a volume of 20 &#956;L, containing 250 ng of pDNA. Therefore, each percentage can also be converted to the mass of pDNA turned to Form II or III. For example, for complex <bold>4a</bold> at a 1 mM concentration, 41.2% of pDNA was cleaved to Form II, which is 103 ng of pDNA, or at a 3 mM concentration, 46.2% corresponds to 115.5 ng of pDNA. Quantification allows us to compare the specific complexes more precisely. As is obvious from the electrophoresis images, complex <bold>4a</bold> has impressive activity at concentration 5 mM (100% cleavage to Form III), but complex <bold>4c</bold> showed almost complete cleavage to Form II already at 3 mM. Complex <bold>4b</bold> with a copper/ligand ratio of 1:2 shows different behavior, with cleaving properties similar to the other complexes at 1 mM (41.5% Form II), but with only a small increase in activity with an increase in concentration. Some aggregation might be present at higher concentrations, keeping the amount of reactive monomer at a lower level.</p></sec><sec id="sec2dot6-molecules-30-03461"><title>2.6. Interaction of Complexes Studied with BSA</title><p>Serum albumin is the most abundant protein present in the blood and its main function is to be a carrier for both exogenous and endogenous substances. The binding affinity between bioactive compounds and serum albumin plays a significant role in the design of novel drugs [<xref rid="B48-molecules-30-03461" ref-type="bibr">48</xref>]. Serum albumin can also accumulate in tumor tissue and can serve as a potential macromolecular carrier for the delivery of anticancer agents to solid tumors [<xref rid="B49-molecules-30-03461" ref-type="bibr">49</xref>].</p><p>The interaction between antitumor drugs and serum albumin can affect the bioavailability and toxicity of these agents. Bovine serum albumin (BSA) represents a well-recognized model for the investigation of intermolecular interactions with drugs due to its high structural similarity to human serum albumin [<xref rid="B50-molecules-30-03461" ref-type="bibr">50</xref>].</p><p>The fluorescence emission spectra of BSA show intense fluorescence emission at 336 nm upon excitation at 280 nm. This is due to the presence of two tryptophan residues (Trp134 and Trp212). Fluorescence quenching data were analyzed to obtain various binding parameters for the interaction of complexes <bold>4a</bold>&#8211;<bold>c</bold> with BSA. The BSA emission spectra in the presence of complexes are shown in <xref rid="molecules-30-03461-f008" ref-type="fig">Figure 8</xref>A and <xref rid="app1-molecules-30-03461" ref-type="app">Figure S4-1</xref>.</p><p>The graph of relative BSA fluorescence intensity with increasing complex concentration exhibited a significant quenching of fluorescence up to 48&#8211;56% (<xref rid="molecules-30-03461-f008" ref-type="fig">Figure 8</xref>B). The maximum emission peak of BSA shifted blue, indicating that hydrophobicity increased, and polarity decreased in the microenvironment of the amino acid residues of BSA [<xref rid="B51-molecules-30-03461" ref-type="bibr">51</xref>]. These results may indicate the strong interaction between studied complexes within an albumin tryptophan environment.</p><p>The interaction of complexes with serum albumin was characterized by the Stern&#8211;Volmer constant <italic toggle="yes">K<sub>sv</sub></italic> and the quenching constant <italic toggle="yes">k</italic><sub>q</sub>, which was calculated using the Stern&#8211;Volmer equation (<xref rid="app1-molecules-30-03461" ref-type="app">Figure S4-2</xref>) together with the associate binding constant <italic toggle="yes">K<sub>BSA</sub></italic> and the number of binding sites per albumin <italic toggle="yes">n</italic> determined from the Scatchard equations (Equation (6), <xref rid="app1-molecules-30-03461" ref-type="app">Figure S4-3</xref>); the values are summarized in <xref rid="molecules-30-03461-t006" ref-type="table">Table 6</xref>.</p><p>Three mechanisms have been proposed for the quenching of protein fluorescence emission: static, dynamic and a combination of the two mechanisms. The static mechanism requires a drug&#8211;protein complex formation at ground state. The dynamic mechanism is based on the collision between drug molecules and proteins. In the combined mechanism, both collisions between the drug and the protein and the formation of a drug&#8211;protein complex play their role [<xref rid="B15-molecules-30-03461" ref-type="bibr">15</xref>].</p><p>The presented values of the quenching constant <italic toggle="yes">k</italic><sub>q</sub> of the complexes (10<sup>12</sup> M<sup>&#8722;1</sup>s<sup>&#8722;1</sup>) are greater than the 10<sup>10</sup> M<sup>&#8722;1</sup>s<sup>&#8722;1</sup> value which represents a typical value for the maximum scatter collision quenching constant of various quenchers with biopolymers. These large Stern&#8211;Volmer values of <italic toggle="yes">k</italic><sub>q</sub> for the complexes indicate that quenching is performed through a static quenching mechanism [<xref rid="B17-molecules-30-03461" ref-type="bibr">17</xref>,<xref rid="B52-molecules-30-03461" ref-type="bibr">52</xref>,<xref rid="B53-molecules-30-03461" ref-type="bibr">53</xref>]. In the static quenching mechanism, it is assumed that the binding and free molecules reach an equilibrium, and the binding sites are similar and independent [<xref rid="B54-molecules-30-03461" ref-type="bibr">54</xref>].</p><p>The <italic toggle="yes">k</italic><sub>q</sub> values reported in this work are in good agreement with the values reported in the literature for BSA and other copper(II) Schiff base complexes [<xref rid="B32-molecules-30-03461" ref-type="bibr">32</xref>,<xref rid="B55-molecules-30-03461" ref-type="bibr">55</xref>,<xref rid="B56-molecules-30-03461" ref-type="bibr">56</xref>,<xref rid="B57-molecules-30-03461" ref-type="bibr">57</xref>]. The Stern&#8211;Volmer curve for all complexes had a linear plot (<xref rid="molecules-30-03461-f008" ref-type="fig">Figure 8</xref>B and <xref rid="app1-molecules-30-03461" ref-type="app">Figure S4-2</xref>), indicating the presence of static quenching. The formation of a complex in ground state between BSA and Cu complexes was also confirmed by analysis of the UV&#8211;Vis absorption spectrum. The protein titration curve for the study complex&#8211;BSA interaction was measured preliminarily for complexes <bold>4a</bold> and <bold>4c</bold>. <xref rid="app1-molecules-30-03461" ref-type="app">Figure S4-4</xref> (representative spectrum) shows that the UV&#8211;Vis absorbance intensity decreased regularly with an increasing concentration of <bold>4c</bold>, indicating that the BSA molecules associated with <bold>4c</bold> and formed a BSA complex.</p><p>This again confirmed a static quenching mechanism. The interaction of BSA with metal complexes could result in absorption change of BSA at a 278 nm wavelength, associated with the polarity of the microenvironment around the BSA tyrosine and tryptophan residues. [<xref rid="B58-molecules-30-03461" ref-type="bibr">58</xref>] A hyperchromic shift [<xref rid="B17-molecules-30-03461" ref-type="bibr">17</xref>,<xref rid="B59-molecules-30-03461" ref-type="bibr">59</xref>] or hypochromic effect [<xref rid="B60-molecules-30-03461" ref-type="bibr">60</xref>] of BSA absorption intensity caused by interaction of metal complexes with BSA is usually described.</p><p>The calculated number of binding sites for albumin&#8212;<italic toggle="yes">n</italic> (0,94&#8211;1.1623)&#8212;could mean that there was one independent class of complex binding sites on albumin. The calculated <italic toggle="yes">K<sub>BSA</sub></italic> binding constant for the studied complexes (of order 10<sup>4</sup>) is in the optimal range assumed for a serum albumin drug-delivery system (with <italic toggle="yes">K<sub>sv</sub></italic> within 10<sup>2</sup>&#8211;10<sup>8</sup>; binding constant <italic toggle="yes">K<sub>BSA</sub></italic> within 10<sup>4</sup>&#8211;10<sup>6</sup>) [<xref rid="B48-molecules-30-03461" ref-type="bibr">48</xref>,<xref rid="B61-molecules-30-03461" ref-type="bibr">61</xref>].</p></sec><sec id="sec2dot7-molecules-30-03461"><title>2.7. Cytotoxicity Based on Mitochondrial Activity</title><p>The resazurin-based model that monitors mitochondrial activity is widely used as an indicator of cell viability, proliferation and cytotoxicity. This method is based on the reduction of resazurin to resorufin by mitochondrial enzymes, as carriers of diaphorase activities, like NADPH-dehydrogenase, which are responsible for the transference of electrons from NADPH<sup>+</sup>, H<sup>+</sup> to resazurin. The reduction of resazurin correlates with the number of live bacterial or mammalian cells or fungi [<xref rid="B62-molecules-30-03461" ref-type="bibr">62</xref>]. Furthermore, <italic toggle="yes">S. cerevisiae</italic> is an established model system for eukaryotic organisms [<xref rid="B62-molecules-30-03461" ref-type="bibr">62</xref>,<xref rid="B63-molecules-30-03461" ref-type="bibr">63</xref>,<xref rid="B64-molecules-30-03461" ref-type="bibr">64</xref>]. They have conserved cellular processes with high homology to those of humans. They proliferate rapidly and are even used as a model to study the effects of anticancer agents [<xref rid="B65-molecules-30-03461" ref-type="bibr">65</xref>]. The use of <italic toggle="yes">S. cerevisiae</italic> in resazurin redox testing is a good alternative to conventional cell viability testing techniques.</p><p>The absorbance values for reduced and oxidized resazurin (measured at 570 nm and 600 nm) obtained are listed in <xref rid="molecules-30-03461-t007" ref-type="table">Table 7</xref>. The reduction percentage was calculated using the equation Equation (1). The complexes showed excellent cytotoxic activity ranging from 67.1 to 99.0% depending on the concentration of the added complex (<xref rid="molecules-30-03461-t007" ref-type="table">Table 7</xref>, <xref rid="app1-molecules-30-03461" ref-type="app">Figures S5-2 to S5-4</xref>). Complex <bold>4c</bold> was most effective (94.8%) already at 1 &#215; 10<sup>&#8722;3</sup> M, followed by <bold>4b</bold> and, surprisingly, <bold>4a</bold> being least active. At higher concentrations, experiments showed cell death above 90%, with similar activities for all three complexes.</p></sec><sec id="sec2dot8-molecules-30-03461"><title>2.8. Cancer Cell Cytotoxicity by MTT Assay</title><p>The cytotoxicity study of the prepared copper(II) complexes was performed using the MTT assay on human cell lines&#8212;A549 (adenocarcinoma human alveolar basal epithelial cell line), HepG2 (human liver cancer cell line) and HEL (human lung fibroblast cell line, normal cells). Cytotoxicity was measured at various sample concentration ranges after 24 and 72 h; however, at 24 h the cytotoxicity was low. After 72 h, the activity reached good levels, especially against HepG2 cells. The IC<sub>50</sub> values were calculated based on the measured data for all prepared complexes and the standard cisplatin (<xref rid="molecules-30-03461-f009" ref-type="fig">Figure 9</xref> and <xref rid="molecules-30-03461-t008" ref-type="table">Table 8</xref>). The IC<sub>50</sub> profiles of all complexes show interesting cytotoxicity against HepG2 with <bold>4a</bold> (17.9 &#177; 2.6 &#956;M) and <bold>4c</bold> (21.6 &#177; 4.9 &#956;M) achieving activity comparable to cisplatin (16.0 &#177; 3.4 &#956;M). All complexes show lower IC<sub>50</sub> values for HepG2 cancer cells (18&#8211;33 &#956;M) than for normal HEL cells (44&#8211;66 &#956;M), which is also analogous to cisplatin. A very interesting feature is that the IC50s for HEL in the case of <bold>4a</bold> and <bold>4c</bold> is about 3-times higher than for HepG2. On the other hand, the IC<sub>50</sub> values for A549 cells were relatively high, with the best IC50 achieved for <bold>4a</bold> at 66.4 &#177; 6.2 &#956;M. Complex <bold>4b</bold> has the least favorable IC50 for all three cell types.</p><p>Cytotoxicity measured against HepG2 cells has an interesting correlation with the pDNA cleavage experiments, where the <bold>4a</bold> and <bold>4c</bold> complexes also showed better cleaving properties with 100% cleavage to Form III at 5 mM for <bold>4a</bold> and 100% cleavage of pDNA to Form II at 3 mM for <bold>4c</bold>. On the other hand, the binding experiments with ct-DNA showed almost identical values for all three complexes, with <bold>4a</bold> being the better EB displacer and <bold>4c</bold> showing the best activities in the absorption titration experiment. The resazurin method used to measure mitochondrial activities showed the main difference of the complexes at 1 mM, with <bold>4c</bold> showing the best results, suggesting cytotoxicity at the mitochondrial level or also on the mitochondrial level [<xref rid="B66-molecules-30-03461" ref-type="bibr">66</xref>]. It could also be related to the ROS production which copper, especially Cu(I), can stimulate in cells [<xref rid="B67-molecules-30-03461" ref-type="bibr">67</xref>]. Increased oxidative stress in cells caused by the presence of copper can lead to cell death (cuproptosis) by mitochondrial damage, interfering with the tricarboxylic acid cycle by copper binding to specialized sulfur-containing proteins or a loss of mitochondrial membrane potential. This prevents mitochondrial function, can lead to morphological changes within the mitochondria and finally leads to cell death [<xref rid="B68-molecules-30-03461" ref-type="bibr">68</xref>,<xref rid="B69-molecules-30-03461" ref-type="bibr">69</xref>]. Due to this, it was also interesting to study the ability of the complexes to undergo a single electron absorption or release where copper could change from II to I and back (radical scavenging or SOD mimetic activity). This process can be simulated by radicals capable of giving or taking one electron to or from copper, other metals or even organic molecules. This is a process that also occurs in SOD enzymes, and thus many coordination compounds able to do this are also called SOD mimetics [<xref rid="B70-molecules-30-03461" ref-type="bibr">70</xref>].</p></sec><sec id="sec2dot9-molecules-30-03461"><title>2.9. SOD Mimetic Activity</title><p>The radical scavenging ability with respect to the SOD mimetic activity of the prepared complexes was determined by the INT method. This method is based on a competitive reaction with the superoxide anion radical from KO<sub>2</sub> between the measured compound (complex) and 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2<italic toggle="yes">H</italic>-tetrazolium chloride (INT). INT reacts with the single electron of O<sub>2</sub><sup>&#8722;</sup> and produces blue-green formazane detected as light absorption at 500 nm. Complexes with good antiradical activity also react with O<sub>2</sub><sup>&#8722;</sup>, and as a result of this, less formazane is formed. Complexes with very good activity can almost completely inhibit the transfer of electrons on INT.</p><p>The first type of antiradical activity measurements involved the determination of inhibition percent values of electron transfer on INT at specific concentrations (<xref rid="molecules-30-03461-t009" ref-type="table">Table 9</xref>). Two concentrations were selected to achieve good solubility of the complexes (4 and 1 mM for <bold>4a</bold> and <bold>4c</bold>, 2 and 1 mM for <bold>4b</bold>). The complex <bold>4b</bold> dissolved readily at a concentration of 4 mM, but the mixture was very dark, making measurements at 500 nm difficult. Therefore, a less concentrated initial solution was used (2 mM) as the higher concentration. In total, 0.5 mL of the initial solutions was used to prepare sample solutions that also contained INT and KO<sub>2</sub> solutions and DMSO with an overall volume of 3.5 mL. The resulting concentrations were c<sub>1</sub> = 0.572 mM, c<sub>1*</sub> = 0.286 mM and c<sub>2</sub> = 0.143 mM, respectively. Complexes <bold>4a</bold> and <bold>4c</bold> once again provided high percentages at c<sub>1</sub> (approximately 96&#8211;99%) but the activity dropped below 24% at c<sub>2</sub>, while complex <bold>4b</bold> maintained mediocre activity at both concentrations. It seems that the concentration increase had only a small effect on the activity of <bold>4b</bold>; something similar was also observed in the DNA cleavage study for complex <bold>4b</bold>. The complexes were compared with the model compound cystamine, which was used as a standard for superoxide antiradical scavenging due to the presence of a free thionyl group, which is also present in glutathione.</p><p>To improve the comparability of SOD mimetic activity, IC<sub>50</sub> concentrations were determined by performing a series of measurements with decreasing concentration. IC<sub>50</sub> values were calculated from the trend function equation as the concentration with 50% inhibition of electron transfer on INT (<xref rid="molecules-30-03461-t010" ref-type="table">Table 10</xref>). The IC<sub>50</sub> values confirmed that complex <bold>4c</bold> was the most effective radical scavenger, followed by <bold>4a</bold>. The least active was complex <bold>4b</bold>, for which 50% inhibition was reached in the &gt;1 mM range, the same as cystamine.</p><p>Comparing the results from the radical scavenging measurements with the cytotoxicity showed certain common features. Antimitochondrial cytotoxicity (resazurin method) showed high activity, especially for complex <bold>4c</bold> (above 94%), which also showed the highest DNA cleavage at 3 mM. The SOD-IC50 value was lowest for complex <bold>4a</bold>, which also showed the best IC50 values in the MTT cytotoxicity test against both cancer cell types, but was also the only complex capable of performing double-strand cleavage on pDNA with 100% efficiency, but at 5 mM. It would seem that while <bold>4c</bold> also relies on mitochondrial toxicity, <bold>4a</bold> might make use of some ROS generation at higher concentrations.</p></sec></sec><sec id="sec3-molecules-30-03461"><title>3. Materials and Methods</title><sec id="sec3dot1-molecules-30-03461"><title>3.1. Instrumentation and Materials Used in Synthesis</title><p>All chemicals for syntheses were reagent grade and were used as received from Sigma-Aldrich (Merck, Taufkirchen, Germany), Acros Organics (Thermo Fisher Scientific Inc., Waltham, MA, USA), and Alfa-Aesar (Thermo Fisher Scientific, Waltham, MA, USA), except for methanol which was dried using predrying with calcium oxide and reflux with magnesium activated with iodine and distillation.</p><p>All NMR spectra were measured on a Varian Gemini 2000 spectrometer (Varian Medical Systems, Palo Alto, CA, USA) at working frequencies of 300 MHz for <sup>1</sup>H NMR and 75 MHz for <sup>13</sup>C NMR. Spectra were measured in CDCl<sub>3</sub>, using TMS as an internal standard. For NMR signal assignment, the numbering always starts on the phenolic ring with 1 on the carbon where the iminomethyl is located (1&#8211;6, Ar), followed by the two carbons in the linker between the aromatic rings (7 and 8), the methoxyphenyl has its own numbering (1&#8242;&#8211;6&#8242;, Ar&#8242;) and the carbon of the methoxy group is numbered 9. Infrared spectra were recorded on a Nicolet 6700 FT-IR spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) in the range of 500&#8211;4000 cm<sup>&#8722;1</sup> and the samples were in the oil or solid state. Elemental analysis was measured with the Flash 2000 CHNS-O Analyser (Thermo Fisher Scientific, Waltham, MA, USA). UV&#8211;Vis spectra were measured in DMSO using a Genesys 10S UV&#8211;Vis spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). The HRMS spectra for stability studies were measured by Orbitrap LTQ XL (Thermo Fisher Scientific, Waltham, MA, USA).</p></sec><sec id="sec3dot2-molecules-30-03461"><title>3.2. General Procedure for Synthesis of the Schiff Base Ligands (<italic toggle="yes"><bold>3</bold></italic>)</title><p>In a two-neck flask with a reflux condenser, a mixture of 2-, 3- or 4-methoxybenzylamine (<bold>2a</bold>&#8211;<bold>c</bold>) (1.31 g, 9.58 mmol, 1 mol equiv) in 20 mL of dry methanol was prepared. The mixture of salicylaldehyde (<bold>1</bold>) (1.17 g, 9.58 mmol, 1 mol equiv) in 5 mL of dry methanol was added via a septum and the whole reaction mixture was heated with reflux while monitored by TLC (hexane/ethyl acetate = 19:1). After 1&#8211;2 h, the reaction came to completion and the mixture was cooled down to room temperature. Methanol was evaporated, which resulted in a deep yellow oil. The oil was washed three times with diethyl ether (20 mL) and dried at low pressure to obtain products <bold>3a</bold>&#8211;<bold>c</bold> as yellow syrupy oils.</p><p><bold>2-[(2-Methoxy-benzylimino)-methyl]-phenol (Sal-2-MeOBn, 3a)</bold> was obtained as yellow oil in 2.17 g (93%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, ppm) &#948;: 8.40 (s, 1H, C7-H), 7.23&#8211;7.33 (m, 4H, C4-H, C6-H, C4&#8242;-H a C6&#8242;-H), 6.83&#8211;6.97 (m, 4H, C3-H, C5-H, C3&#8242;-H and C5&#8242;-H), 4.80 (s, 2H, C8-H<sub>2</sub>), 3.85 (s, 3H, C9-H<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, ppm) &#948;: 165.5 (C7), 161.4 (C2&#8242;), 157.1 (C2), 132.1 (C4), 131.3 a 129.1 (C6 a C6&#8242;), 128.4 (C4&#8242;), 126.3 (C1&#8242;), 120.6 (C5 or C5&#8242;), 119.0 (C1), 118.4 (C5 or C5&#8242;), 117.1 (C3), 110.3 (C3&#8242;), 57.7 (C9), 55.3 (C8). Elemental analysis calculated for C<sub>15</sub>H<sub>15</sub>NO<sub>2</sub> (M<sub>r</sub> = 241.29): C 74.67; H 6.27; N 5.81%; measured: C 74.38; H 6.15; N 5.72%. IR (oil, cm<sup>&#8722;1</sup>): 2962 (w), 2843 (w), 1633 (s, N=C), 1601 (w), 1578 (m), 1492 (s), 1457 (s), 1444 (m), 1428 (m), 1412 (w), 1279 (s), 1239 (s), 1212 (w), 1199 (w), 1175 (w), 1165 (w), 1149 (w), 1110 (m), 1061 (s), 1022 (s), 996 (w), 963 (w), 941 (w), 844 (m), 755 (s), 735 (m), 656 (m).</p><p><bold>2-[(3-Methoxy-benzylimino)-methyl]-phenol (Sal-3-MeOBn, 3b)</bold> was prepared as yellow oil in 2.31 g (99%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, ppm) &#948;: 8.42 (s, 1H, C7-H), 7.24&#8211;7.34 (m, 3H, C4-H, C6-H a C5&#8242;-H), 6.81&#8211;6.98 (m, 5H, C3-H, C5-H, C2&#8242;-H, C4&#8242;-H, C6&#8242;-H), 4.77 (s, 2H, C8-H<sub>2</sub>). 3.80 (s, 3H, C9-H<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, ppm) &#948;: 165.6 (C7), 161.1 (C3&#8242;), 159.8 (C2), 139.7 (C1&#8242;), 132.3 (C4), 131.4 (C6), 129.7 (C5&#8242;), 120.0 (C1), 118.8 and 118.6 (C5 and C6&#8242;), 117.0 (C3), 113.4 (C2&#8242;), 112.7 (C4&#8242;), 63.1 (C9), 55.2 (C8). Elemental analysis calculated for C<sub>15</sub>H<sub>15</sub>NO<sub>2</sub> (M<sub>r</sub> = 241.29): C 74.67; H 6.27; N 5.81%; measured: C 74.56; H 6.21; N 5.75%. IR (oil, cm<sup>&#8722;1</sup>): 2997 (w), 2907 (w), 2831 (m), 1634 (s, N=C), 1601 (s), 1582 (w), 1491 (s), 1461 (s), 1425 (s), 1221 (w), 1205 (w), 1154 (s), 1115 (m), 1068 (m), 1044 (s), 997 (w), 967 (m), 937 (w), 909 (m), 851 (s), 839 (m), 785 (s), 754 (s), 747 (m), 732 (w), 692 (s), 656 (m), 626 (w).</p><p><bold>2-[(4-Methoxy-benzylimino)-methyl]-phenol (Sal-4-MeOBn, 3c)</bold> was obtained as a yellow oil in 2.24 g (97%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>, ppm) &#948;: 8.38 (s, 1H, C7-H), 7.29 (ddd, 1H, <italic toggle="yes">J</italic>(3,4) = 8.2 Hz, <italic toggle="yes">J</italic>(4,5) = 7.3 Hz, <italic toggle="yes">J</italic>(4,6) = 1.6 Hz, C4-H), 7.19&#8211;7.26 (m, 3H, C6, C2&#8242;, C6&#8242;), 6.95 (dd, 1H, <italic toggle="yes">J</italic>(3,4) = 8.2 Hz, <italic toggle="yes">J</italic>(3,5) = 1.0 Hz, C3-H), 6.84&#8211;6.90 (m, 3H, C5, C3&#8242;, C5&#8242;), 4.72 (s, 2H, C8-H<sub>2</sub>), 3.79 (s, 3H, C9-H<sub>3</sub>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>, ppm) &#948;: 165.2 (C7), 161.1 (C4&#8242;), 158.9 (C2), 132.4 (C4), 131.3 (C6), 130.2 (C1&#8242;), 129.0 (C2&#8242; a C6&#8242;), 118.8 (C1), 118.5 (C5), 117.0 (C3), 114.1 (C3&#8242; and C5&#8242;), 62.5 (C9), 55.3 (C8). Elemental analysis calculated for C<sub>15</sub>H<sub>15</sub>NO<sub>2</sub> (M<sub>r</sub> = 241.29): C 74.67; H 6.27; N 5.81%; measured: C 74.54; H 6.31; N 5.78%. IR (oil, cm<sup>&#8722;1</sup>): 3009 (w), 2900 (w), 2838 (w), 1629 (s, N=C), 1609 (s), 1585 (m), 1512 (s), 1464 (w), 1443 (w), 1421 (w), 1375 (w), 1327 (w), 1301 (m), 1283 (s), 1247 (s), 1215 (w), 1183 (s), 1150 (w), 1119 (w), 1040 (m), 1031 (s), 989 (w), 951 (w), 864 (w), 848 (s), 837 (s), 825 (s), 782 (w), 764 (s), 738 (w), 718 (w).</p></sec><sec id="sec3dot3-molecules-30-03461"><title>3.3. General Procedure of Synthesis of Schiff Base Ligand Complexes (<italic toggle="yes"><bold>4</bold></italic>)</title><p>The solution of CuCl<sub>2</sub>.2H<sub>2</sub>O (141 mg, 0.829 mmol, 1 mol equiv) in 5 mL of methanol was added to the solution of the Schiff base <bold>3</bold> (200 mg, 0.829 mmol, 1 mol equiv) in 10 mL of methanol at room temperature. This caused a dramatic color change and, after 1&#8211;2 days, the product precipitated in the form of a dark green powder or crystals. The product was isolated by vacuum filtration and washed with a small amount of methanol and diethyl ether.</p><p><bold>[Cu<sub>2</sub> (Sal-2-MeOBn)<sub>2</sub> Cl<sub>2</sub>] (4a)</bold> was isolated as crystals in 125 mg (44.5%). Elemental analysis calculated for C<sub>30</sub>H<sub>28</sub>Cl<sub>2</sub>Cu<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M<sub>r</sub> = 678.55): C 53.10; H 4.16; N 4.13%; measured: C 53.42; H 4.17; N 4.22%. IR (solid, cm<sup>&#8722;1</sup>): 3007 (w), 2962 (w), 2934 (w), 2832 (w), 1626 (s, C=N), 1596 (s), 1558 (s), 1495 (m), 1476 (m), 1463 (w), 1432 (m), 1411 (w), 1347 (m), 1325 (m), 1276 (s), 1254 (s), 1224 (m), 1162 (m), 1122 (s), 1049 (m), 1030 (s), 990 (w), 954 (w), 897 (m), 838 (m), 763 (s), 744 (s), 658 (m), 613 (m). UV&#8211;Vis (nm): 278, 298, 370, 712.</p><p><bold>[Cu (Sal-3-MeOBn)<sub>2</sub>] (4b</bold>) was obtained as a powder in 102 mg (45%). Elemental analysis calculated for C<sub>30</sub>H<sub>28</sub>CuN<sub>2</sub>O<sub>4</sub> (M<sub>r</sub> = 544.10): C 66.22; H 5.19; N 5.15%; measured: C 66.00; H 5.22; N 5.23%. IR (solid, cm<sup>&#8722;1</sup>): 3087 (w), 3026 (w), 2999 (w), 2960 (w), 2936 (w), 2837 (w), 1621 (s, C=N), 1614 (s), 1584 (m), 1542(s), 1489 (m), 1473 (s), 1451 (m), 1437 (s), 1399 (m), 1350 (m), 1328 (s), 1292 (w), 1259 (s), 1230 (w), 1201 (m), 1146 (s), 1127 (w), 1045 (s), 989 (m), 911 (m), 884 (w), 873 (m), 853 (w), 809 (w), 780 (m), 750 (s), 737 (m), 697 (s), 612 (m). UV&#8211;Vis (nm): 278, 300, 365, 695. MS (pos., aq. DMSO) m/z: 544.1550 (theor. 544.1554).</p><p><bold>[Cu<sub>2</sub> (Sal-4-MeOBn)<sub>2</sub> Cl<sub>2</sub>] (4c)</bold> was isolated as a powder in 107 mg (38%). Elemental analysis calculated for C<sub>30</sub>H<sub>28</sub>Cl<sub>2</sub>Cu<sub>2</sub>N<sub>2</sub>O<sub>4</sub> (M<sub>r</sub> = 678.55): C 53.10; H 4.16; N 4.13%; measured: C 53.44; H 4.19; N 4.19%. IR (solid, cm<sup>&#8722;1</sup>): 3064 (w), 3000 (w), 2925 (w), 2834 (w), 1629 (s, C=N), 1599 (s), 1559 (s), 1507 (s), 1475 (m), 1463 (w), 1444 (m), 1407 (w), 1334 (w), 1299 (w), 1276 (s), 1249 (s), 1216 (m), 1172 (m), 1158 (m), 1112 (w), 1044 (w), 1030 (s), 997 (w), 957 (w), 897 (m), 848 (m), 831 (m), 795 (w), 768 (s), 715 (w), 658 (m), 626 (w). UV&#8211;Vis (nm): 278, 297, 361, 709.</p></sec><sec id="sec3dot4-molecules-30-03461"><title>3.4. Stability Measurements</title><p>The stability of the complexes was studied by using UV&#8211;Vis. All prepared complexes were sufficiently soluble in all measurements used. The solutions of the complexes in DMSO and citrate buffer solution were studied over up to 72 h (<xref rid="app1-molecules-30-03461" ref-type="app">Figures S0-2&#8211;S0-7 in Supplementary Materials</xref>). We conducted several more UV&#8211;Vis spectroscopic studies, where we proved complex formation and that the complexes are the same in solid form and right after dissolution in DMSO and one hour later (<xref rid="app1-molecules-30-03461" ref-type="app">Figure S0-8</xref>). We could see no changes for complexes <bold>4a</bold>&#8211;<bold>c</bold> and the spectra remained the same as in the long-term study.</p></sec><sec id="sec3dot5-molecules-30-03461"><title>3.5. X-Ray Structure Analysis</title><p>A STOE STADIVARI diffractometer (STOE Corporation, Chicago, IL, USA) was used to measure the diffraction data of complex <bold>4a</bold>. The diffractometer was equipped with Dectris Pilatus 300 K detector, with a Genix3D Cu HF source (Cu-K<sub>&#945;</sub>, &#955; = 1.54186 &#197;) at 100 K using a nitrogen gas open-flow cooler Cobra (Oxford Cryosystems, Oxford, UK). Data reduction was performed using the X-Area software package (version 1.84, STOE &amp; Cie GmbH, Darmstadt, Germany). The crystal structure of complex <bold>4a</bold> was solved in the OLEX2 software (version 1.5) [<xref rid="B71-molecules-30-03461" ref-type="bibr">71</xref>] using the SHELXT-2015 program via Intrinsic Phasing [<xref rid="B72-molecules-30-03461" ref-type="bibr">72</xref>] and further refined with SHELXL-2015 by the least-squares procedure on F<sup>2</sup> [<xref rid="B73-molecules-30-03461" ref-type="bibr">73</xref>]. All non-hydrogen atoms were refined with anisotropic thermal parameters. Hydrogen atom positions were optimized under the constraints of bonding to their parent atoms, an aliphatic C&#8211;H bond length of 0.99 &#197;, with an aromatic C&#8211;H bond length of 0.95 &#197;, a methyl group C&#8211;H bond length of 0.98&#197; and a C&#8211;H bond (on the imine carbon) length of 0.95&#197;. The temperature factors of hydrogen atoms were U<sub>iso</sub>(H) = 1.2 U<sub>eq</sub>(C), for the methyl group U<sub>iso</sub>(H) = 1.5 U<sub>eq</sub>(C) and the water molecule U<sub>iso</sub>(H) = 1.5 U<sub>eq</sub>(O). For molecular images, the DIAMOND program (version 2.1e) [<xref rid="B74-molecules-30-03461" ref-type="bibr">74</xref>] and the MERCURY (version 3.8) program [<xref rid="B75-molecules-30-03461" ref-type="bibr">75</xref>] were used.</p><p>Accession Codes</p><p>The crystallographic data used in this paper can be accessed as CCDC 2367651 via <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="www.ccdc.cam.ac.uk/data_request/cif">www.ccdc.cam.ac.uk/data_request/cif</uri>, by e-mailing <email>data_request@ccdc.cam.ac.uk</email> or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033.</p></sec><sec id="sec3dot6-molecules-30-03461"><title>3.6. EPR Studies</title><p>EPR spectra were recorded using an X-band CW EPR spectrometer Bruker EMX Plus (Bruker, Germany) with a standard TE<sub>102</sub> (ER 4102 ST) rectangular resonator cavity (Bruker, Germany). For spectra acquisition and processing, the software package Bruker Acquisition and WinEPR (version 2.11, Bruker, Bremen, Germany) was used. Solid-state spectra with a linear slope are shown as baseline corrected. The microwave power of 20 mW was tested and considered far below saturation for all samples. All CW EPR spectra were recorded using 100 kHz field modulation with 5 G (0.5 mT) amplitude. Due to the expectation of ZFS (zero field splitting), spectra were recorded within the entire available field range of our spectrometer (0&#8211;1500 mT). For solid-state measurements, a small amount of solid state powder was placed into a thin-wall quartz EPR tube (internal diameter 3 mm). Low-temperature measurements were performed using a special Dewar finger inset inserted directly into the EPR resonator cavity, enabling the direct placement of the sample into liquid nitrogen surroundings. Room temperature was 300 K. Spectra were simulated using the Easyspin simulation program (version 6.0.10) [<xref rid="B76-molecules-30-03461" ref-type="bibr">76</xref>,<xref rid="B77-molecules-30-03461" ref-type="bibr">77</xref>] with Simultispin extension [<xref rid="B78-molecules-30-03461" ref-type="bibr">78</xref>]. The integral intensity of the signal in spectra is not directly related just to the number of spins in the sample because of the complex nature of EPR signal intensity, which is dependent on many factors that influence the sensitivity of detection. Quantity was not a goal within this measurement and would require another different experimental approach.</p></sec><sec id="sec3dot7-molecules-30-03461"><title>3.7. DNA Cleavage Assay</title><p>The ability of copper(II) complexes to cleave DNA was examined by following the conversion of supercoiled plasmid DNA (Form I) to the open-circular DNA (Form II) and/or linear DNA (forms using agarose gel electrophoresis to separate the cleavage products [<xref rid="B79-molecules-30-03461" ref-type="bibr">79</xref>,<xref rid="B80-molecules-30-03461" ref-type="bibr">80</xref>].</p><p>In general, 250 ng of the DNA plasmid pBBR 322 (in 25 mM TRIS-HCl buffer solution, pH 7.5) was treated with different concentrations (1 mM, 3 mM and 5 mM) of the copper(II) complex (dissolved in DMSO) for 3 h at 37 &#176;C. After that, each reaction was quenched by adding 4 &#956;L of a Smart Glow Loading Dye<sup>&#174;</sup> (loading buffer solution with 0.01% Safe Green dye, 50% glycerol and 250 mM EDTA, pH 8.0) and the sample subjected to electrophoresis (MyGel Mini electrophoresis system<sup>&#174;</sup>, Accuris, Edison, NJ, USA) on a 0.9% agarose gel containing TAE buffer (40 mM TRIS, 20 mM acetic acid and 1 mM EDTA) at a voltage of 55 V/40 mA for about 1.5 h. As a &#8220;running buffer&#8221;, TAE buffer (40 mM TRIS, 20 mM acetic acid and 1 mM EDTA) was used. The resulting gels were visualized with UV light and scanned by a mobile device, an Apple iPhone 11 cam 26 mm f1.8. DNA cleaving activities were quantified using the &#8220;geneQUANT software&#8221; (version 4.3.9, Cleaver Scientific, Rugby, UK).</p></sec><sec id="sec3dot8-molecules-30-03461"><title>3.8. DNA Binding Study by Absorption Titration</title><p>The interactions of prepared complexes <bold>4a&#8211;c</bold> with ct-DNA have been studied by UV&#8211;Vis monitored titration. The ct-DNA solution was prepared by dissolving 6 mg of ct-DNA in 5 mL of citrate buffer (composed of 15 mM sodium citrate and 150 mM sodium chloride mixture solution, at pH = 7.0). The concentration of ct-DNA was then determined by UV&#8211;Vis spectroscopy with the molar absorption coefficient of ct-DNA at 260 nm (6600 M<sup>&#8722;1</sup>cm<sup>&#8722;1</sup>). The studied complexes were dissolved in DMSO, from which working solutions were prepared by dilution using citrate buffer solution. Increasing concentrations of ct-DNA were then added to a buffer/DMSO solution (&lt;1% DMSO) of the corresponding complex (1 &#215; 10<sup>&#8722;4</sup> mol&#8901;ml<sup>&#8722;1</sup>) [<xref rid="B81-molecules-30-03461" ref-type="bibr">81</xref>].</p><p>For the values of the binding strength of the interaction between the complex and the DNA molecule, binding constants K<sub>b</sub> were calculated by the ratio of slope to the y intercept in the plots [DNA]/(&#949;<sub>A</sub>-&#949;<sub>f</sub>) compared to [DNA], according to the Wolfe&#8211;Shimer equation (Equation (1)):<disp-formula id="FD1-molecules-30-03461"><label>(1)</label><mml:math id="mm1" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi></mml:mrow><mml:mrow><mml:mi>A</mml:mi></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mo>[</mml:mo><mml:mi>D</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mo>]</mml:mo></mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>+</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi></mml:mrow><mml:mrow><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi></mml:mrow><mml:mrow><mml:mi>f</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></disp-formula>
where [DNA] is the concentration of DNA in base pairs, <italic toggle="yes">&#949;<sub>f</sub></italic> is the extinction coefficient of the free complex at the corresponding &#955;<sub>max</sub>, <italic toggle="yes">&#949;<sub>A</sub></italic> = A<sub>obsd</sub>/[compound] and <italic toggle="yes">&#949;<sub>b</sub></italic> is the extinction coefficient of the complex in the fully bound form.</p><p>Control measurements with DMSO were carried out with no changes in the ct-DNA spectra observed.</p></sec><sec id="sec3dot9-molecules-30-03461"><title>3.9. EB&#8211;DNA Displacement Method</title><p>Competitive-binding experiments to determine the displacement of the intercalator ethidium bromide (EB) from the EB&#8211;DNA adduct were conducted by fluorescence spectroscopy. To prepare the EB&#8211;DNA adduct, 20 &#956;M EB and 54 &#956;M ct-DNA were added to citrate buffer (sodium citrate at 15 mM and sodium chloride at 150 mM at pH = 7.0) [<xref rid="B82-molecules-30-03461" ref-type="bibr">82</xref>]. The addition of increasing concentrations of complexes <bold>4a</bold>&#8211;<bold>c</bold> (c = 1 mM) to a solution of the EB&#8211;DNA complex corresponded to the intercalating effect of the complexes. The concentration of the added complexes ranged from 0 to 0.2 mM. Fluorescence emission spectra were recorded in the range of 550&#8211;800 nm with an excitation wavelength of 515 nm. The complexes did not show any fluorescence emission bands in their own solution or in the presence of ct-DNA or EB. Quenching of the EB&#8211;DNA emission band by the compounds <bold>4a</bold>&#8211;<bold>c</bold> was calculated using the Stern&#8211;Volmer equation (Equations (2)&#8211;(4)).</p><p>The extent of the inner-filter effect can be roughly estimated with the following equation:<disp-formula id="FD2-molecules-30-03461"><label>(2)</label><mml:math id="mm2" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>r</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi></mml:mrow></mml:msub><mml:mo>&#215;</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi><mml:mo>(</mml:mo><mml:mi>&#955;</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>x</mml:mi><mml:mi>c</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mi>c</mml:mi><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:msup><mml:mo>&#215;</mml:mo><mml:msup><mml:mrow><mml:mn>10</mml:mn></mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi>&#949;</mml:mi><mml:mo>(</mml:mo><mml:mi>&#955;</mml:mi></mml:mrow><mml:mrow><mml:mi>e</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo><mml:mi>c</mml:mi><mml:mi>d</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:msup></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic toggle="yes">I<sub>corr</sub></italic> is the corrected intensity, <italic toggle="yes">I<sub>meas</sub></italic> is the measured intensity, c is the quencher concentration, d is the width of the cuvette (1 cm) and <italic toggle="yes">&#949;<sub>(&#955;exc)</sub></italic> and <italic toggle="yes">&#949;<sub>(&#955;em)</sub></italic> are the excitation coefficients of the quencher at the excitation and the emission wavelength calculated from the UV&#8211;Vis spectra of the complexes.</p><p>The quenching of the EB&#8211;DNA emission band by compounds was calculated via the Stern&#8211;Volmer equation:<disp-formula id="FD3-molecules-30-03461"><label>(3)</label><mml:math id="mm3" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi>I</mml:mi><mml:mi>o</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>q</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#964;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mi>Q</mml:mi></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>V</mml:mi></mml:mrow></mml:msub><mml:mfenced open="[" close="]" separators="|"><mml:mrow><mml:mi>Q</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math></disp-formula>
where <italic toggle="yes">Io</italic> = the initial fluorescence intensity of the EB&#8211;DNA adduct, and <italic toggle="yes">I</italic> is the fluorescence intensity of the EB&#8211;DNA adduct after the addition of the quencher (studied complexes), <italic toggle="yes">k<sub>q</sub></italic> = the quenching rate constant, <italic toggle="yes">K<sub>SV</sub></italic> = the Stern&#8211;Volmer constant, <italic toggle="yes">&#964;<sub>o</sub></italic> = the average fluorescence lifetime of the EB&#8211;DNA adduct (23 &#215; 10<sup>&#8722;9</sup> s), [Q] = the quencher concentration, respectively, <italic toggle="yes">K<sub>SV</sub></italic> (in M<sup>&#8722;1</sup>) can be obtained by the slope of the Stern&#8211;Volmer plot and <italic toggle="yes">k<sub>q</sub></italic> (in M<sup>&#8722;1</sup> s<sup>&#8722;1</sup>) can be calculated from Equation (4):<disp-formula id="FD4-molecules-30-03461"><label>(4)</label><mml:math id="mm4" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>S</mml:mi><mml:mi>V</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi>k</mml:mi></mml:mrow><mml:mrow><mml:mi>q</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi>&#964;</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec3dot10-molecules-30-03461"><title>3.10. Viscosimetric Studies</title><p>Changes in the viscosity of the DNA solution (0.1 mM) were measured in the presence of increasing concentrations of the compounds in citrate buffer solution (15 mM of sodium citrate and 150 mM of sodium chloride at pH = 7.0) at a constant 25 &#176;C. The measurements were performed using the ALPHA L Fungilab rotational viscometer (IKA, Staufen, Germany) at 60 rpm, equipped with an 18 mL ELVAS spindle. The relationship between the relative solution viscosity (&#951;/&#951;<sub>0</sub>) and DNA length (I/I<sub>0</sub>) can be seen in Equation (5), where &#951; and &#951;<sub>0</sub> are the viscosities of DNA in the presence and absence of the studied complex.<disp-formula id="FD5-molecules-30-03461"><label>(5)</label><mml:math id="mm5" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mrow><mml:mfenced separators="|"><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mi mathvariant="sans-serif">&#951;</mml:mi><mml:mrow><mml:msub><mml:mi mathvariant="sans-serif">&#951;</mml:mi><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>3</mml:mn></mml:mrow></mml:msup><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mn>0</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></disp-formula></p></sec><sec id="sec3dot11-molecules-30-03461"><title>3.11. Bovine Serum Albumin Binding Studies</title><p>The BSA binding of complexes <bold>4a</bold>&#8211;<bold>c</bold> was studied by tryptophan fluorescence emission quenching experiments using BSA (3 &#956;M) in citrate buffer solution (containing 15 mM trisodium citrate and 150 mM sodium chloride at pH 7.0). The emission intensity quenching of BSA tryptophan residues at 336 nm was measured by increasing the concentration of the quencher complexes <bold>4a</bold>&#8211;<bold>c</bold> [<xref rid="B83-molecules-30-03461" ref-type="bibr">83</xref>]. The concentration of the added complexes ranged from 0 to 0.2 mM. The fluorescence emission spectra were recorded in the 300&#8211;420 nm range and with an excitation wavelength of 280 nm. The values of the Stern&#8211;Volmer constant <italic toggle="yes">K<sub>SV</sub></italic> (in M<sup>&#8722;1</sup>), the BSA binding constant <italic toggle="yes">K</italic> (in M<sup>&#8722;1</sup>) for the compound&#8211;BSA interaction and the BSA quenching constant <italic toggle="yes">k<sub>q</sub></italic> (in M<sup>&#8722;1</sup> s<sup>&#8722;1</sup>) have been calculated from the Stern&#8211;Volmer (Equations (2)&#8211;(4)). and Scatchard equations (Equation (6)):<disp-formula id="FD6-molecules-30-03461"><label>(6)</label><mml:math id="mm6" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mrow><mml:mrow><mml:mo mathvariant="italic">&#916;</mml:mo><mml:mi>I</mml:mi></mml:mrow><mml:mo>/</mml:mo><mml:mrow><mml:mi>I</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:mrow></mml:mrow><mml:mrow><mml:mo>[</mml:mo><mml:mi>Q</mml:mi><mml:mo>]</mml:mo></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>=</mml:mo><mml:mi>n</mml:mi><mml:mi>K</mml:mi><mml:mo>&#8722;</mml:mo><mml:mi>K</mml:mi><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:mo mathvariant="italic">&#916;</mml:mo><mml:mi>I</mml:mi></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mi>o</mml:mi></mml:mrow></mml:mfrac></mml:mstyle></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>The BSA binding constant <italic toggle="yes">K</italic> (in M<sup>&#8722;1</sup>) can be calculated from the slope of the Scatchard plots, and the number of binding sites per albumin (<italic toggle="yes">n</italic>) is given by the ratio of the y intercept to the slope.</p><p>Also, to prevent the undesirable effects of dilution on peak intensity in these experiments, a correction for working standard solution dilution was completed.</p></sec><sec id="sec3dot12-molecules-30-03461"><title>3.12. Resazurin Cytotoxicity Assay</title><p>The assay is based on the ability of living cells to reduce blue resazurin (7-hydroxy-3<italic toggle="yes">H</italic>-phenoxazin-3-one 10-oxide) to pink resorufin (7-hydroxy-3<italic toggle="yes">H</italic>-phenoxazin-3-one) which is measurable by the UV&#8211;Vis spectrophotometric or fluorometric method (AlamarBlue<sup>TM</sup>). Living cells have active <italic toggle="yes">N</italic>-methylphenazinium methosulfate that catalyzes the redox reaction in mitochondria of NADH and blue resazurin to produce pink resorufin (<xref rid="molecules-30-03461-sch002" ref-type="fig">Scheme 2</xref>) [<xref rid="B83-molecules-30-03461" ref-type="bibr">83</xref>,<xref rid="B84-molecules-30-03461" ref-type="bibr">84</xref>,<xref rid="B85-molecules-30-03461" ref-type="bibr">85</xref>,<xref rid="B86-molecules-30-03461" ref-type="bibr">86</xref>]. This test is used as an oxidation&#8211;reduction indicator in cell viability assays for yeasts and mammalian cells. Reduction of the dye by viable cells decreases the amount of the oxidized form (blue) and, at the same time, increases the amount of its fluorescent intermediate (pink), indicating the degree of cytotoxicity caused by the test material [<xref rid="B83-molecules-30-03461" ref-type="bibr">83</xref>,<xref rid="B84-molecules-30-03461" ref-type="bibr">84</xref>]. The resazurin-based assay shows excellent correlation with reference viability assays such as formazane-based assays (MTT/XTT) and tritiated thymidine-based techniques [<xref rid="B62-molecules-30-03461" ref-type="bibr">62</xref>].</p><p><italic toggle="yes">S. cerevisiae</italic> cells (CCY 21-4-64; Lib&#225;&#328;, Czech Republic) were cultured at 28 &#176;C/24h on Saburaud&#8217;s dextrose agar with chloramphenicol (Merck, Boston, MA, USA). Subsequently, after 24 h, <italic toggle="yes">S. cerevisiae</italic> cells were inoculated into sterile liquid YPD medium (Sigma&#8211;Aldrich, St. Louis, MO, USA) and cultivation continued at 28 &#176;C/24 h. In the exponential growth phase, cells were centrifuged (8.000 g/3 min), washed twice with sterile physiological solution (0.9% NaCl) and pipetted at a concentration of 1 <italic toggle="yes">&#215;</italic> 10<sup>9</sup> cells/mL in sterile microtubes (modified procedure from Bitacura, 2018) [<xref rid="B62-molecules-30-03461" ref-type="bibr">62</xref>]. Sterile physiological solution and copper complexes at concentrations of 1 <italic toggle="yes">&#215;</italic> 10<sup>&#8722;3</sup> M, 3 <italic toggle="yes">&#215;</italic> 10<sup>&#8722;3</sup> M and 5 <italic toggle="yes">&#215;</italic> 10<sup>&#8722;3</sup> M were added to the centrifuged biomass to a total volume of 1 mL and individual samples were cultured in an incubator at 28 &#176;C/3 h. After 3 h, 0.1 mL of Resazurin<sub>OX</sub> (in vitro toxicology assay kit based on resazurin, Sigma, USA) was added to each sample and the samples were allowed to culture for 2 h. After incubation, the biomass in the samples was separated from the supernatant by centrifugation (8000 g/5 min). The separated solution was diluted in a ratio of 1:1 with physiological solution and subjected to the measurement of UV spectra by the spectrophotometric method according to the recommended protocol of the kit manufacturer (Sigma, USA) on a GENESYS 10S UV&#8211;Vis spectrophotometer (Thermo Scientific, USA) in the range of 500&#8211;800 nm, using a 1 cm long cuvette.</p><p>Cells&#8217; innate metabolic was measured by using an established formula for the reduction percentage. The reduction percentage was calculated using the following formula:<disp-formula id="FD7-molecules-30-03461"><label>(7)</label><mml:math id="mm7" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi mathvariant="normal">%</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mstyle scriptlevel="0" displaystyle="true"><mml:mfrac><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">&#400;</mml:mi></mml:mrow><mml:mrow><mml:mi>O</mml:mi><mml:mi>X</mml:mi><mml:mo>_</mml:mo><mml:mn>600</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>&#215;</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>570</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi><mml:mo>_</mml:mo><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">&#400;</mml:mi></mml:mrow><mml:mrow><mml:mi>O</mml:mi><mml:mi>X</mml:mi><mml:mo>_</mml:mo><mml:mn>570</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>&#215;</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi><mml:mo>_</mml:mo><mml:mi>s</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>p</mml:mi><mml:mi>l</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mrow><mml:mi mathvariant="bold">&#400;</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>E</mml:mi><mml:mi>D</mml:mi><mml:mo>_</mml:mo><mml:mn>570</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>&#215;</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>600</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi><mml:mo>_</mml:mo><mml:mi>C</mml:mi><mml:mo>&#8722;</mml:mo></mml:mrow></mml:msub><mml:mo>&#8722;</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="bold">&#400;</mml:mi></mml:mrow><mml:mrow><mml:mi>R</mml:mi><mml:mi>E</mml:mi><mml:mi>D</mml:mi><mml:mo>_</mml:mo><mml:mn>600</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi></mml:mrow></mml:msub><mml:mo>&#215;</mml:mo><mml:msub><mml:mrow><mml:mi>A</mml:mi></mml:mrow><mml:mrow><mml:mn>570</mml:mn><mml:mo>&#160;</mml:mo><mml:mi>n</mml:mi><mml:mi>m</mml:mi><mml:mo>_</mml:mo><mml:mi>C</mml:mi><mml:mo>&#8722;</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mstyle><mml:mo>&#215;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:mrow></mml:math></disp-formula></p><table-wrap position="anchor" id="molecules-30-03461-t010" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t010_Table 10</object-id><label>Table 10</label><caption><p>Molar extinction coefficients for reduced and oxidized resazurin [<xref rid="B87-molecules-30-03461" ref-type="bibr">87</xref>].</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Wavelength</bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Reduced Resazurin (Resorufin)</bold>
<break/>
<bold>&#400;<sub>RED</sub></bold>
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Oxidized Resazurin</bold>
<break/>
<bold>&#400;</bold>
<bold>
<sub>OX</sub>
</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">570 nm</td><td align="center" valign="middle" rowspan="1" colspan="1">155,677</td><td align="center" valign="middle" rowspan="1" colspan="1">80,586</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">600 nm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14,652</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">117,216</td></tr></tbody></table></table-wrap></sec><sec id="sec3dot13-molecules-30-03461"><title>3.13. MTT Cytotoxicity Assay</title><p>The cytotoxicity of the prepared copper(II) complexes in human cell lines was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay following the protocol by Mosmann. Briefly, A549 (human lung epithelial cells, carcinoma), HepG2 (human liver epithelial cells, carcinoma) and HEL (human lung fibroblast cells, normal) cells were seeded in plastic 96-well plates at a density of 1.5&#8211;2 &#215; 10<sup>4</sup> cells per well. The cells were treated for 72 h with complexes <bold>4a</bold>&#8211;<bold>c</bold> and cisplatin dissolved in DMSO and incubated at 37 &#176;C in a 5% CO<sub>2</sub> atmosphere. After the treatment, the samples were washed with phosphate-buffered saline (PBS), followed by 4 h of incubation with 1 mg/mL of MTT. Subsequently, the MTT solution was removed, and the formed formazane solids were dissolved in dimethyl sulfoxide for 30 min. The photometric evaluation (at 540 nm and 690 nm) was carried out using an xMark&#8482; Microplate Absorbance Spectrophotometer (Bio-Rad, Hercules, CA, USA) [<xref rid="B88-molecules-30-03461" ref-type="bibr">88</xref>].</p><p>Cell lines</p><p>A549 (ATCC<sup>&#174;</sup> CCL-185), HepG2 (ATCC<sup>&#174;</sup> HB-8065) and HEL299 (ATCC<sup>&#174;</sup> CCL-137) cells were obtained from Lambda Life (Bratislava, Slovakia). A549 cells were kept in Dulbecco&#8217;s Modified Eagle&#8217;s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics (penicillin and streptomycin). HepG2 cells were kept in Williams medium supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics (penicillin and streptomycin). HEL299 cells were kept in Minimum Essential Medium (MEM) supplemented with 10% fetal bovine serum (FBS), 1% antibiotics (penicillin and streptomycin) and 1% non-essential amino acids (NEAA). The cells were cultured in a humidified atmosphere of 5% CO<sub>2</sub> at 37 &#176;C. Once the cells reached approximately 80% confluence, they were harvested and subcultured after trypsin treatment.</p></sec><sec id="sec3dot14-molecules-30-03461"><title>3.14. Radical Scavenging Assay</title><p>The method is based on the agent 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride (INT), able to scavenge a superoxide radical anion from KO<sub>2</sub>. The reaction produces a blue-green formazane, which is detected as light absorption at 500 nm. The radical scavengers (measured complexes) compete with INT for radicals and reduce the formation of formazane and light absorption at 500 nm. Antiradical activity was measured on a Synergy HT BioTek spectrophotometer. DMSO was used as the solvent for the complex and KO<sub>2</sub> (saturated solution). The INT initial solution (4 M) was prepared in a sodium tetraborate buffer solution with pH adjusted to 7.1 with HCl [<xref rid="B24-molecules-30-03461" ref-type="bibr">24</xref>,<xref rid="B25-molecules-30-03461" ref-type="bibr">25</xref>].</p><p>For each measurement, an initial solution of the sample (0.5 mL) of a specific concentration (4&#8211;0.1 mM) was prepared in DMSO. Due to the addition of INT (0.5 mL) and KO<sub>2</sub> (0.5 mL) solutions and additional DMSO (2 mL), the concentrations of the measured complexes decreased seven times (3.5 mL of total mixture). Each result was the average value of three parallel measurements expressed with a standard deviation (more information in the <xref rid="app1-molecules-30-03461" ref-type="app">Supplementary Materials</xref>). For the determination of SOD-IC50, several measurements with decreasing sample concentration were performed. The percentage of inhibition had a decreasing tendency with decreasing concentration. A linear trend function of the percentage of inhibition and negative logarithm of concentration was used to calculate the SOD-IC<sub>50</sub> value as the concentration with 50% inhibition of INT&#8211;formazane formation.</p></sec></sec><sec sec-type="conclusions" id="sec4-molecules-30-03461"><title>4. Conclusions</title><p>Schiff base ligands (<bold>3a</bold>&#8211;<bold>c</bold>) derived from salicylaldehyde and 2-, 3- and 4-methoxybenzylamines were prepared. These ligands were used to prepare three copper(II) complexes (<bold>4a</bold>&#8211;<bold>c</bold>) from which <bold>4a</bold> could also be studied with X-ray structure analysis. The analysis of complex <bold>4a</bold> revealed a dimeric structure in the solid state, and we also expect a similar structure in complex <bold>4c</bold>. In complex <bold>4b</bold> with a ratio of 1:2, we expect both ligands to bind in bidentate style (N,O) on the same copper center.</p><p>The prepared complexes were used in DNA binding studies by absorption titration and EB&#8211;DNA displacement methods. The EB&#8211;DNA method did not reveal significant differences between the complexes; this is probably due to the similar planar shape of the Schiff base. The best binding properties were observed for <italic toggle="yes">ortho-</italic> and <italic toggle="yes">para</italic>-substituted derivatives (<bold>4a</bold>, <bold>4c</bold>). The BSA binding studies also revealed similar results, with <bold>4c</bold> being the best binder. However, all complexes had a binding constant range for reversible BSA binding. The DNA cleavage studies (pDNA model) showed up to 100% cleavage to Form II at 3 mM for complex <bold>4c</bold> and to Form III at 5 mM for complex <bold>4a</bold>. The cytotoxicity of the complexes was studied in a cell survival model monitoring mitochondrial activity of <italic toggle="yes">S. cerevisiea</italic> (resazurin model) and the MTT assay on cancer cell lines (HepG2 and A549) versus HEL fibroblast cells. The resazurin model revealed a high activity of <bold>4c</bold> with around 95% cell death at 1 mM concentrations. The MTT assay uncovered good activities of <bold>4a</bold> and <bold>4c</bold> against HepG2 cells, comparable with cisplatin activity. These two complexes provided an IC50 more than three-times higher for HEL noncancer cells than for HepG2 cells. The position of the methoxy group on the ligands played a role in the activities of the copper(II) complexes. Complex <bold>4a</bold> with <italic toggle="yes">ortho</italic> position of the methoxy group was highly active in most of our studies, closely followed by <bold>4c</bold> with <italic toggle="yes">para</italic> position. The exception was cytotoxicity based on mitochondrial activity, where <bold>4c</bold> was much more active.</p><p>Overall, complexes <bold>4a</bold> and <bold>4c</bold> show a combination of activities that all contribute to the overall cytotoxicity. The DNA binding and cleavage, the halting of mitochondrial activity and the oxidation&#8211;reduction reaction provided by the copper center all play a role in this effect.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors would like to express their gratitude to Karol Lu&#353;pai from the Institute of Physical Chemistry and Chemical Physics, Faculty of Chemical and Food Technology, Slovak Technical University of Technology in Bratislava, for EPR spectra measurements.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-molecules-30-03461"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.mdpi.com/article/10.3390/molecules30173461/s1">https://www.mdpi.com/article/10.3390/molecules30173461/s1</uri>, the supplementary material file contains additional figures and measured data cited in the article text as, for example, Figure S1-1, Table S2-1 or Equation (S3-1).</p><supplementary-material id="molecules-30-03461-s001" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-30-03461-s001.zip" position="float" orientation="portrait"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, L.L. and J.V.; methodology, L.L., P.H., J.K., B.S. and J.V.; software, L.L. and P.H.; validation, J.V. and F.J.; formal analysis, L.L.; investigation, L.L. and J.V.; resources, L.L., P.H. and J.V.; data curation, L.L., F.J. and J.V.; writing&#8212;original draft preparation, L.L. and J.V.; writing&#8212;review and editing, L.L.; visualization, L.L.; supervision, L.L.; project administration, L.L.; funding acquisition, J.V., P.H. and F.J. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article/<xref rid="app1-molecules-30-03461" ref-type="app">Supplementary Materials</xref>. Further inquiries can be directed to the corresponding authors.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><array orientation="portrait"><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">A549</td><td align="left" valign="top" rowspan="1" colspan="1">adenocarcinoma human alveolar basal epithelial cell line</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BSA</td><td align="left" valign="top" rowspan="1" colspan="1">bovine serum albumin</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ct-DNA</td><td align="left" valign="top" rowspan="1" colspan="1">calf thymus DNA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">DMSO</td><td align="left" valign="top" rowspan="1" colspan="1">dimethyl sulfoxide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">EB</td><td align="left" valign="top" rowspan="1" colspan="1">ethidium bromide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HepG2</td><td align="left" valign="top" rowspan="1" colspan="1">human liver epithelial cell line, carcinoma</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">HEL</td><td align="left" valign="top" rowspan="1" colspan="1">lung fibroblast cell line, noncancerous</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">INT</td><td align="left" valign="top" rowspan="1" colspan="1">2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyl-2H-tetrazolium chloride</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NADH</td><td align="left" valign="top" rowspan="1" colspan="1">nicotinamide adenine dinucleotide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MTT</td><td align="left" valign="top" rowspan="1" colspan="1">3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">pDNA</td><td align="left" valign="top" rowspan="1" colspan="1">plasmid DNA</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">ROS</td><td align="left" valign="top" rowspan="1" colspan="1">reactive oxygen species</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SOD</td><td align="left" valign="top" rowspan="1" colspan="1">superoxide dismutase</td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-molecules-30-03461"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arjmand</surname><given-names>F.</given-names></name><name name-style="western"><surname>Muddassir</surname><given-names>M.</given-names></name><name name-style="western"><surname>Yousuf</surname><given-names>I.</given-names></name></person-group><article-title>Design and synthesis of enantiomeric (R)- and (S)-copper(II) and diorganotin(IV)-based antitumor agents: Their in vitro DNA binding profile, cleavage efficiency and cytotoxicity studies</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2014</year><volume>136</volume><fpage>62</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2014.04.024</pub-id><pub-id pub-id-type="pmid">24857791</pub-id></element-citation></ref><ref id="B2-molecules-30-03461"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>DNA cleavage, DNA/HSA binding study, and antiproliferative activity of a phenolate-bridged binuclear copper(II) complex</article-title><source>Biometals</source><year>2019</year><volume>32</volume><fpage>227</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1007/s10534-019-00172-w</pub-id><pub-id pub-id-type="pmid">30659452</pub-id></element-citation></ref><ref id="B3-molecules-30-03461"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Da Silva</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>De Luca</surname><given-names>A.</given-names></name><name name-style="western"><surname>Squitti</surname><given-names>R.</given-names></name><name name-style="western"><surname>Rongioletti</surname><given-names>M.</given-names></name><name name-style="western"><surname>Rossi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Machado</surname><given-names>C.M.L.</given-names></name><name name-style="western"><surname>Cerchiaro</surname><given-names>G.</given-names></name></person-group><article-title>Copper in tumors and the use of copper-based compounds in cancer treatment</article-title><source>J. Inorg. Biochem.</source><year>2022</year><volume>226</volume><elocation-id>111634</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2021.111634</pub-id><pub-id pub-id-type="pmid">34740035</pub-id></element-citation></ref><ref id="B4-molecules-30-03461"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zehra</surname><given-names>S.</given-names></name><name name-style="western"><surname>Tabassum</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arjmand</surname><given-names>F.</given-names></name></person-group><article-title>Biochemical Pathways of Copper Complexes: Progress over the past 5 years</article-title><source>Drug Discov. Today</source><year>2021</year><volume>26</volume><fpage>1086</fpage><lpage>1096</lpage><pub-id pub-id-type="doi">10.1016/j.drudis.2021.01.015</pub-id><pub-id pub-id-type="pmid">33486113</pub-id></element-citation></ref><ref id="B5-molecules-30-03461"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrez&#225;lov&#225;</surname><given-names>L.</given-names></name><name name-style="western"><surname>Orsz&#225;ghov&#225;</surname><given-names>Z.</given-names></name></person-group><article-title>Covalent and noncovalent interactions of coordination compounds with DNA: An overview</article-title><source>J. Inorg. Biochem.</source><year>2021</year><volume>225</volume><elocation-id>111624</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2021.111624</pub-id><pub-id pub-id-type="pmid">34653826</pub-id></element-citation></ref><ref id="B6-molecules-30-03461"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santini</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pellei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Gandin</surname><given-names>V.</given-names></name><name name-style="western"><surname>Porchia</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tisato</surname><given-names>F.</given-names></name><name name-style="western"><surname>Marzano</surname><given-names>C.</given-names></name></person-group><article-title>Advances in Copper Complexes as Anticancer Agents</article-title><source>Chem. Rev.</source><year>2014</year><volume>114</volume><fpage>815</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1021/cr400135x</pub-id><pub-id pub-id-type="pmid">24102434</pub-id></element-citation></ref><ref id="B7-molecules-30-03461"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Muniyandi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Pravin</surname><given-names>N.</given-names></name><name name-style="western"><surname>Raman</surname><given-names>N.</given-names></name></person-group><article-title>Impact of metallonucleases on DNA interactions: Structural validation and in-vitro antibiogram assay</article-title><source>Inorg. Chem. Comm.</source><year>2014</year><volume>46</volume><fpage>60</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.inoche.2014.05.003</pub-id></element-citation></ref><ref id="B8-molecules-30-03461"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erkkila</surname><given-names>K.E.</given-names></name><name name-style="western"><surname>Odom</surname><given-names>D.T.</given-names></name><name name-style="western"><surname>Barton</surname><given-names>J.K.</given-names></name></person-group><article-title>Recognition and Reaction of Metallointercalators with DNA</article-title><source>Chem. Rev.</source><year>1999</year><volume>99</volume><fpage>2777</fpage><lpage>2795</lpage><pub-id pub-id-type="doi">10.1021/cr9804341</pub-id><pub-id pub-id-type="pmid">11749500</pub-id></element-citation></ref><ref id="B9-molecules-30-03461"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mehring</surname><given-names>A.</given-names></name><name name-style="western"><surname>Erdmann</surname><given-names>N.</given-names></name><name name-style="western"><surname>Walther</surname><given-names>J.</given-names></name><name name-style="western"><surname>Stiefelmaier</surname><given-names>J.</given-names></name><name name-style="western"><surname>Strieth</surname><given-names>D.</given-names></name><name name-style="western"><surname>Ulber</surname><given-names>R.</given-names></name></person-group><article-title>A simple and low-cost resazurin assay for vitality assessment across species</article-title><source>J. Biotechnol.</source><year>2021</year><volume>333</volume><fpage>63</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2021.04.010</pub-id><pub-id pub-id-type="pmid">33933484</pub-id></element-citation></ref><ref id="B10-molecules-30-03461"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erxleben</surname><given-names>A.</given-names></name></person-group><article-title>Interactions of copper complexes with nucleic acids</article-title><source>Coord. Chem. Rev.</source><year>2018</year><volume>360</volume><fpage>92</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2018.01.008</pub-id></element-citation></ref><ref id="B11-molecules-30-03461"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barone</surname><given-names>G.</given-names></name><name name-style="western"><surname>Terenzi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Lauria</surname><given-names>A.</given-names></name><name name-style="western"><surname>Almerico</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Leal</surname><given-names>J.M.</given-names></name><name name-style="western"><surname>Busto</surname><given-names>N.</given-names></name><name name-style="western"><surname>Garcia</surname><given-names>B.</given-names></name></person-group><article-title>DNA-binding of nickel(II), copper(II) and zinc(II) complexes: Structure&#8211;affinity relationships</article-title><source>Coord. Chem. Rev.</source><year>2013</year><volume>257</volume><fpage>2848</fpage><lpage>2862</lpage><pub-id pub-id-type="doi">10.1016/j.ccr.2013.02.023</pub-id></element-citation></ref><ref id="B12-molecules-30-03461"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghanghas</surname><given-names>P.</given-names></name><name name-style="western"><surname>Choudhary</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>D.</given-names></name><name name-style="western"><surname>Poonia</surname><given-names>K.</given-names></name></person-group><article-title>Coordination metal complexes with Schiff bases: Useful pharmacophores with comprehensive biological applications</article-title><source>Inorg. Chem. Comm.</source><year>2021</year><volume>130</volume><fpage>108710</fpage><pub-id pub-id-type="doi">10.1016/j.inoche.2021.108710</pub-id></element-citation></ref><ref id="B13-molecules-30-03461"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kargar</surname><given-names>H.</given-names></name><name name-style="western"><surname>Behjatmanesh-Ardakani</surname><given-names>R.</given-names></name><name name-style="western"><surname>Torabi</surname><given-names>V.</given-names></name><name name-style="western"><surname>Kashani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chavoshpour-Natanzi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Kazemi</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Mirkhani</surname><given-names>V.</given-names></name><name name-style="western"><surname>Sahraei</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tahir</surname><given-names>M.N.</given-names></name><name name-style="western"><surname>Ashfaq</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Synthesis, characterization, crystal structures, DFT, TD-DFT, molecular docking and DNA binding studies of novel copper(II) and zinc(II) complexes bearing halogenated bidentate N,O-donor Schiff base ligands</article-title><source>Polyhedron</source><year>2021</year><volume>195</volume><fpage>114988</fpage><pub-id pub-id-type="doi">10.1016/j.poly.2020.114988</pub-id></element-citation></ref><ref id="B14-molecules-30-03461"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahraki</surname><given-names>S.</given-names></name></person-group><article-title>Schiff base compounds as artificial metalloenzymes</article-title><source>Colloids Surf. B</source><year>2022</year><volume>218</volume><fpage>112727</fpage><pub-id pub-id-type="doi">10.1016/j.colsurfb.2022.112727</pub-id><pub-id pub-id-type="pmid">35921691</pub-id></element-citation></ref><ref id="B15-molecules-30-03461"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahraki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Samareh Delarami</surname><given-names>H.</given-names></name><name name-style="western"><surname>Mansouri-Torshizi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nouri</surname><given-names>H.</given-names></name></person-group><article-title>Investigation of kinetics and thermodynamics in the interaction process between two pyridine derived Schiff base complexes and catalase</article-title><source>J. Mol. Liq.</source><year>2021</year><volume>334</volume><fpage>116527</fpage><pub-id pub-id-type="doi">10.1016/j.molliq.2021.116527</pub-id></element-citation></ref><ref id="B16-molecules-30-03461"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tabassum</surname><given-names>S.</given-names></name><name name-style="western"><surname>Amir</surname><given-names>S.</given-names></name><name name-style="western"><surname>Arjmand</surname><given-names>F.</given-names></name><name name-style="western"><surname>Pettinari</surname><given-names>C.</given-names></name><name name-style="western"><surname>Marchetti</surname><given-names>F.</given-names></name><name name-style="western"><surname>Masciocchi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Lupidi</surname><given-names>G.</given-names></name><name name-style="western"><surname>Pettinari</surname><given-names>R.</given-names></name></person-group><article-title>Mixed-ligand Cu(II)&#8211;vanillin Schiff base complexes; effect of coligands on their DNA binding, DNA cleavage, SOD mimetic and anticancer activity</article-title><source>Europ. J. Med. Chem.</source><year>2013</year><volume>60</volume><fpage>216</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2012.08.019</pub-id><pub-id pub-id-type="pmid">23291123</pub-id></element-citation></ref><ref id="B17-molecules-30-03461"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahraki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Heidari Majd</surname><given-names>M.</given-names></name><name name-style="western"><surname>Heydari</surname><given-names>A.</given-names></name></person-group><article-title>Novel tetradentate Schiff base zinc(II) complex as a potential antioxidant and cancer chemotherapeutic agent: Insights from the photophysical and computational approach</article-title><source>J. Mol. Struct.</source><year>2019</year><volume>1177</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2018.10.005</pub-id></element-citation></ref><ref id="B18-molecules-30-03461"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chidambaram</surname><given-names>B.</given-names></name><name name-style="western"><surname>Anand</surname><given-names>N.</given-names></name><name name-style="western"><surname>Varma</surname><given-names>S.R.</given-names></name><name name-style="western"><surname>Ramamurthy</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vichitra</surname><given-names>C.</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>A.</given-names></name><name name-style="western"><surname>Mahalakshmi</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Essa</surname><given-names>M.M.</given-names></name></person-group><article-title>Superoxide dismutase and neurological disorders</article-title><source>IBRO Neurosci. Rep.</source><year>2024</year><volume>16</volume><fpage>373</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.ibneur.2023.11.007</pub-id><pub-id pub-id-type="pmid">39007083</pub-id><pub-id pub-id-type="pmcid">PMC11240301</pub-id></element-citation></ref><ref id="B19-molecules-30-03461"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Policar</surname><given-names>C.</given-names></name><name name-style="western"><surname>Bouvet</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bertrand</surname><given-names>H.C.</given-names></name><name name-style="western"><surname>Delsuc</surname><given-names>N.</given-names></name></person-group><article-title>SOD mimics: From the tool box of the chemists to cellular studies</article-title><source>Curr. Opi. Chem. Biol.</source><year>2022</year><volume>67</volume><elocation-id>102109</elocation-id><pub-id pub-id-type="doi">10.1016/j.cbpa.2021.102109</pub-id><pub-id pub-id-type="pmid">35066373</pub-id></element-citation></ref><ref id="B20-molecules-30-03461"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Singh</surname><given-names>S.</given-names></name></person-group><article-title>Antioxidant nanozymes as next-generation therapeutics to free radical-mediated inflammatory diseases: A comprehensive review</article-title><source>Int. J. Biol. Macromol.</source><year>2024</year><volume>260</volume><elocation-id>129374</elocation-id><pub-id pub-id-type="doi">10.1016/j.ijbiomac.2024.129374</pub-id><pub-id pub-id-type="pmid">38242389</pub-id></element-citation></ref><ref id="B21-molecules-30-03461"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahraki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Vaziri</surname><given-names>E.</given-names></name><name name-style="western"><surname>Saboury</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Fan</surname><given-names>K.</given-names></name></person-group><article-title>Biomedical potential of nanozymes: Harnessing redox enzyme mimicry for theranostic applications</article-title><source>Coord. Chem. Rev.</source><year>2024</year><volume>517</volume><fpage>215937</fpage><pub-id pub-id-type="doi">10.1016/j.ccr.2024.215937</pub-id></element-citation></ref><ref id="B22-molecules-30-03461"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name><name name-style="western"><surname>Shang</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>You</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name></person-group><article-title>Antihyperglycemic and neuroprotective effects of one novel Cu&#8211;Zn SOD mimetic</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2011</year><volume>21</volume><fpage>4320</fpage><lpage>4324</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2011.05.051</pub-id><pub-id pub-id-type="pmid">21669524</pub-id></element-citation></ref><ref id="B23-molecules-30-03461"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Klanicov&#225;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tr&#225;vn&#237;&#269;ek</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Van&#269;o</surname><given-names>J.</given-names></name><name name-style="western"><surname>Popa</surname><given-names>I.</given-names></name><name name-style="western"><surname>&#352;indel&#225;&#345;</surname><given-names>Z.</given-names></name></person-group><article-title>Dinuclear copper(II) perchlorate complexes with 6-(benzylamino)purine derivatives: Synthesis, X-ray structure, magnetism and antiradical activity</article-title><source>Polyhedron</source><year>2010</year><volume>29</volume><fpage>2582</fpage><lpage>2589</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2010.06.007</pub-id></element-citation></ref><ref id="B24-molecules-30-03461"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Van&#269;o</surname><given-names>J.</given-names></name><name name-style="western"><surname>&#352;vajlenov&#225;</surname><given-names>O.</given-names></name><name name-style="western"><surname>Ra&#269;ansk&#225;</surname><given-names>E.</given-names></name><name name-style="western"><surname>Musel&#237;k</surname><given-names>J.</given-names></name><name name-style="western"><surname>Valentov&#225;</surname><given-names>J.</given-names></name></person-group><article-title>Antiradical activity of different copper(II) Schiff base complexes and their effect on alloxan-induced diabetes</article-title><source>J. Trace Elem. Med. Biol.</source><year>2004</year><volume>18</volume><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="doi">10.1016/j.jtemb.2004.07.003</pub-id><pub-id pub-id-type="pmid">15646262</pub-id></element-citation></ref><ref id="B25-molecules-30-03461"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lintnerov&#225;</surname><given-names>L.</given-names></name><name name-style="western"><surname>Valentov&#225;</surname><given-names>L.</given-names></name><name name-style="western"><surname>Herich</surname><given-names>P.</given-names></name><name name-style="western"><surname>Ko&#382;&#237;&#353;ek</surname><given-names>J.</given-names></name><name name-style="western"><surname>Dev&#237;nsky</surname><given-names>F.</given-names></name></person-group><article-title>Synthesis and antiradical activity of novel copper(II) complexes of long chain reduced Schiff base ligands</article-title><source>Monatsh. Chem.</source><year>2018</year><volume>149</volume><fpage>901</fpage><lpage>911</lpage><pub-id pub-id-type="doi">10.1007/s00706-017-2137-z</pub-id></element-citation></ref><ref id="B26-molecules-30-03461"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cai</surname><given-names>H.</given-names></name><name name-style="western"><surname>He</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Lu</surname><given-names>S.</given-names></name></person-group><article-title>Enzyme-mimetic antioxidant nanomaterials for ROS scavenging: Design, classification, and biological applications</article-title><source>Coord. Chem. Rev.</source><year>2024</year><volume>500</volume><fpage>215536</fpage><pub-id pub-id-type="doi">10.1016/j.ccr.2023.215536</pub-id></element-citation></ref><ref id="B27-molecules-30-03461"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mapuskar</surname><given-names>K.A.</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>C.M.</given-names></name><name name-style="western"><surname>Spitz</surname><given-names>D.R.</given-names></name><name name-style="western"><surname>Batinic-Haberle</surname><given-names>I.</given-names></name><name name-style="western"><surname>Allen</surname><given-names>B.G.</given-names></name><name name-style="western"><surname>Oberley-Deegan</surname><given-names>R.E.</given-names></name></person-group><article-title>Utilizing Superoxide Dismutase Mimetics to Enhance Radiation Therapy Response While Protecting Normal Tissues</article-title><source>Semin. Rad. Oncol.</source><year>2019</year><volume>29</volume><fpage>72</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.semradonc.2018.10.005</pub-id><pub-id pub-id-type="pmcid">PMC6310053</pub-id><pub-id pub-id-type="pmid">30573187</pub-id></element-citation></ref><ref id="B28-molecules-30-03461"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marzano</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pellei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Tisato</surname><given-names>F.</given-names></name><name name-style="western"><surname>Santini</surname><given-names>C.</given-names></name></person-group><article-title>Copper complexes as anticancer agents</article-title><source>Anticancer. Agents Med. Chem.</source><year>2009</year><volume>9</volume><fpage>185</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.2174/187152009787313837</pub-id><pub-id pub-id-type="pmid">19199864</pub-id></element-citation></ref><ref id="B29-molecules-30-03461"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matela</surname><given-names>G.</given-names></name></person-group><article-title>Schiff bases and complexes: A review on anti-cancer activity</article-title><source>Anticancer Agents Med. Chem.</source><year>2020</year><volume>20</volume><fpage>1908</fpage><lpage>1917</lpage><pub-id pub-id-type="doi">10.2174/1871520620666200507091207</pub-id><pub-id pub-id-type="pmid">32379596</pub-id></element-citation></ref><ref id="B30-molecules-30-03461"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pages</surname><given-names>B.J.</given-names></name><name name-style="western"><surname>Ang</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Wright</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Aldrich-Wright</surname><given-names>J.R.</given-names></name></person-group><article-title>Metal complex interactions with DNA</article-title><source>Dalton Trans.</source><year>2015</year><volume>44</volume><fpage>3505</fpage><lpage>3526</lpage><pub-id pub-id-type="doi">10.1039/C4DT02700K</pub-id><pub-id pub-id-type="pmid">25427534</pub-id></element-citation></ref><ref id="B31-molecules-30-03461"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aleksi&#263;</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Kapetanovi&#263;</surname><given-names>V.</given-names></name></person-group><article-title>An overview of the optical and electrochemical methods for detection of DNA-drug interactions</article-title><source>Acta Chim. Slov.</source><year>2014</year><volume>61</volume><fpage>555</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">25286211</pub-id></element-citation></ref><ref id="B32-molecules-30-03461"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andrez&#225;lov&#225;</surname><given-names>L.</given-names></name><name name-style="western"><surname>Pl&#353;&#237;kov&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Jano&#269;kov&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ko&#328;arikov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>&#381;it&#328;anov&#225;</surname><given-names>I.</given-names></name><name name-style="western"><surname>Koh&#250;tov&#225;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ko&#382;urkov&#225;</surname><given-names>M.</given-names></name></person-group><article-title>DNA/BSA binding ability and genotoxic effect of mono- and binuclear copper (II) complexes containing a Schiff base derived from salicylaldehyde and D, L-glutamic acid</article-title><source>J. Organomet. Chem.</source><year>2017</year><volume>827</volume><fpage>67</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1016/j.jorganchem.2016.11.007</pub-id></element-citation></ref><ref id="B33-molecules-30-03461"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reddy</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Shilpa</surname><given-names>A.</given-names></name></person-group><article-title>Oxidative and hydrolytic DNA cleavage by Cu(II) complexes of salicylidene tyrosine Schiff base and 1,10 phenanthroline/bipyridine</article-title><source>Polyhedron</source><year>2011</year><volume>30</volume><fpage>565</fpage><lpage>572</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2010.11.015</pub-id></element-citation></ref><ref id="B34-molecules-30-03461"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundaravadivel</surname><given-names>E.</given-names></name><name name-style="western"><surname>Muthusamy</surname><given-names>K.</given-names></name><name name-style="western"><surname>Varghese</surname><given-names>B.</given-names></name></person-group><article-title>Synthesis, characterization and electrochemical behavior of new acyclic mono and binuclear copper (II) complexes: DNA binding and cleavage studies</article-title><source>Polyhedron</source><year>2013</year><volume>61</volume><fpage>33</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.poly.2013.04.057</pub-id></element-citation></ref><ref id="B35-molecules-30-03461"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dimitrakopoulou</surname><given-names>A.</given-names></name><name name-style="western"><surname>Dendrinou-Samara</surname><given-names>C.</given-names></name><name name-style="western"><surname>Pantazaki</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Alexiou</surname><given-names>M.</given-names></name><name name-style="western"><surname>Nordlander</surname><given-names>E.</given-names></name><name name-style="western"><surname>Kessissoglou</surname><given-names>D.P.</given-names></name></person-group><article-title>Synthesis, structure and interactions with DNA of novel tetranuclear, [Mn4(II/II/II/IV)] mixed valence complexes</article-title><source>J. Inorg. Biochem.</source><year>2008</year><volume>102</volume><fpage>618</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2007.10.005</pub-id><pub-id pub-id-type="pmid">18055016</pub-id></element-citation></ref><ref id="B36-molecules-30-03461"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sirajuddin</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ali</surname><given-names>S.</given-names></name><name name-style="western"><surname>Badshah</surname><given-names>A.</given-names></name></person-group><article-title>Drug&#8211;DNA interactions and their study by UV&#8211;Visible, fluorescence spectroscopies and cyclic voltammetry</article-title><source>J. Photochem. Photobiol. B Biol.</source><year>2013</year><volume>124</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2013.03.013</pub-id><pub-id pub-id-type="pmid">23648795</pub-id></element-citation></ref><ref id="B37-molecules-30-03461"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bukonji&#263;</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Tomovi&#263;</surname><given-names>D.L.</given-names></name><name name-style="western"><surname>Stankovi&#263;</surname><given-names>A.S.</given-names></name><name name-style="western"><surname>Jevti&#263;</surname><given-names>V.V.</given-names></name><name name-style="western"><surname>Ratkovi&#263;</surname><given-names>Z.R.</given-names></name><name name-style="western"><surname>Bogojeski</surname><given-names>J.V.</given-names></name><name name-style="western"><surname>Milanovi&#263;</surname><given-names>J.Z.</given-names></name><name name-style="western"><surname>Dordevi&#263;</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Arsenijevi&#263;</surname><given-names>A.N.</given-names></name><name name-style="western"><surname>Milanovi&#263;</surname><given-names>M.Z.</given-names></name><etal/></person-group><article-title>Synthesis, characterization and biological activity of copper(II) complexes with ligands derived from &#946;-amino acids</article-title><source>Transit. Met. Chem.</source><year>2019</year><volume>44</volume><fpage>65</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1007/s11243-018-0270-0</pub-id></element-citation></ref><ref id="B38-molecules-30-03461"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>W.D.</given-names></name><name name-style="western"><surname>Ratmeyer</surname><given-names>L.</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>M.</given-names></name><name name-style="western"><surname>Strekowski</surname><given-names>L.</given-names></name><name name-style="western"><surname>Boykin</surname><given-names>D.</given-names></name></person-group><article-title>The search for structure-specific nucleic acid-interactive drugs: Effects of compound structure on RNA versus DNA interaction strength</article-title><source>Biochemistry</source><year>1993</year><volume>32</volume><fpage>4098</fpage><lpage>4104</lpage><pub-id pub-id-type="doi">10.1021/bi00066a035</pub-id><pub-id pub-id-type="pmid">7682441</pub-id></element-citation></ref><ref id="B39-molecules-30-03461"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Banerjee</surname><given-names>D.</given-names></name><name name-style="western"><surname>Pal</surname><given-names>S.K.</given-names></name></person-group><article-title>Simultaneous binding of minor groove binder and intercalator to dodecamer DNA: Importance of relative orientation of donor and acceptor in FRET</article-title><source>J. Phys. Chem. B</source><year>2007</year><volume>111</volume><fpage>5047</fpage><lpage>5052</lpage><pub-id pub-id-type="doi">10.1021/jp0715427</pub-id><pub-id pub-id-type="pmid">17455977</pub-id></element-citation></ref><ref id="B40-molecules-30-03461"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dehkhodaei</surname><given-names>M.</given-names></name><name name-style="western"><surname>Sahihi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Amiri Rudbari</surname><given-names>H.</given-names></name><name name-style="western"><surname>Momenbeik</surname><given-names>F.</given-names></name></person-group><article-title>DNA and HSA interaction of Vanadium (IV), Copper (II), and Zinc (II) complexes derived from an asymmetric bidentate Schiff-base ligand: Multi spectroscopic, viscosity measurements, molecular docking and ONIOM studies</article-title><source>J. Biol. Inorg. Chem.</source><year>2018</year><volume>23</volume><fpage>181</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1007/s00775-017-1505-9</pub-id><pub-id pub-id-type="pmid">29119261</pub-id></element-citation></ref><ref id="B41-molecules-30-03461"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cole</surname><given-names>K.D.</given-names></name><name name-style="western"><surname>Tellez</surname><given-names>C.M.</given-names></name></person-group><article-title>Separation of large circular DNA by electrophoresis in agarose gels</article-title><source>Biotechnol. Prog.</source><year>2002</year><volume>18</volume><fpage>82</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1021/bp010135o</pub-id><pub-id pub-id-type="pmid">11822904</pub-id></element-citation></ref><ref id="B42-molecules-30-03461"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaividhya</surname><given-names>P.</given-names></name><name name-style="western"><surname>Dhivya</surname><given-names>R.</given-names></name><name name-style="western"><surname>Akbarsha</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Palaniandavar</surname><given-names>M.</given-names></name></person-group><article-title>Efficient DNA cleavage mediated by mononuclear mixed ligand copper(II) phenolate complexes: The role of planarity on DNA binding and cleavage and anticancer activity</article-title><source>J. Inorg. Biochem.</source><year>2012</year><volume>114</volume><fpage>94</fpage><lpage>105</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2012.04.018</pub-id><pub-id pub-id-type="pmid">22841366</pub-id></element-citation></ref><ref id="B43-molecules-30-03461"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mamindla</surname><given-names>A.</given-names></name><name name-style="western"><surname>Varadhan</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kartikeyan</surname><given-names>R.</given-names></name><name name-style="western"><surname>Amuthamozhi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Akbarsha</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Rajendiran</surname><given-names>V.</given-names></name></person-group><article-title>Comparative DNA-/BSA-binding, DNA cleavage, and cytotoxic properties of copper(II) amino/salicyl-phenolate Schiff bases (phen) complexes that induce generation of phenoxyl radicals</article-title><source>Polyhedron</source><year>2023</year><volume>243</volume><fpage>116534</fpage><pub-id pub-id-type="doi">10.1016/j.poly.2023.116534</pub-id></element-citation></ref><ref id="B44-molecules-30-03461"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sundaravadivel</surname><given-names>I.</given-names></name><name name-style="western"><surname>Reddy</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Manoj</surname><given-names>D.</given-names></name><name name-style="western"><surname>Rajendran</surname><given-names>S.</given-names></name><name name-style="western"><surname>Kandaswamy</surname><given-names>M.</given-names></name><name name-style="western"><surname>Janakiraman</surname><given-names>M.</given-names></name></person-group><article-title>DNA binding and cleavage studies of copper(II) complex containing N<sub>2</sub>O<sub>2</sub> Schiff base ligand</article-title><source>Inorg. Chim. Acta</source><year>2018</year><volume>482</volume><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1016/j.ica.2018.06.002</pub-id></element-citation></ref><ref id="B45-molecules-30-03461"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Ayodhya</surname><given-names>D.</given-names></name></person-group><article-title>Shivaraj Novel copper (II) binary complexes with N,O-donor isoxazole Schiff base ligands: Synthesis, characterization, DPPH scavenging, antimicrobial, and DNA binding and cleavage studies</article-title><source>Res. Chem.</source><year>2023</year><volume>5</volume><fpage>100845</fpage><pub-id pub-id-type="doi">10.1016/j.rechem.2023.100845</pub-id></element-citation></ref><ref id="B46-molecules-30-03461"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Ajay</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Bhat</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Rao</surname><given-names>C.P.</given-names></name></person-group><article-title>Cu(II) complexes of glyco-imino-aromatic conjugates in DNA binding, plasmid cleavage and cell cytotoxicity</article-title><source>J. Chem. Sci.</source><year>2012</year><volume>124</volume><fpage>1217</fpage><lpage>1228</lpage><pub-id pub-id-type="doi">10.1007/s12039-012-0319-0</pub-id></element-citation></ref><ref id="B47-molecules-30-03461"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ganeshpandian</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ramakrishnan</surname><given-names>S.</given-names></name><name name-style="western"><surname>Palaniandavar</surname><given-names>M.</given-names></name><name name-style="western"><surname>Suresh</surname><given-names>E.</given-names></name><name name-style="western"><surname>Riyasdeen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Akbarsha</surname><given-names>M.A.</given-names></name></person-group><article-title>Mixed ligand copper(II) complexes of 2,9-dimethyl-1,10-phenanthroline: Tridentate 3N primary ligands determine DNA binding and cleavage and cytotoxicity</article-title><source>J. Inorg. Biochem.</source><year>2014</year><volume>140</volume><fpage>202</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2014.07.021</pub-id><pub-id pub-id-type="pmid">25151036</pub-id></element-citation></ref><ref id="B48-molecules-30-03461"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Siddiqui</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ameen</surname><given-names>F.</given-names></name><name name-style="western"><surname>ur Rehman</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sarwar</surname><given-names>T.</given-names></name><name name-style="western"><surname>Tabish</surname><given-names>M.</given-names></name></person-group><article-title>Studying the interaction of drug/ligand with serum albumin</article-title><source>J. Mol. Liq.</source><year>2021</year><volume>336</volume><fpage>116200</fpage><pub-id pub-id-type="doi">10.1016/j.molliq.2021.116200</pub-id></element-citation></ref><ref id="B49-molecules-30-03461"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kratz</surname><given-names>F.</given-names></name><name name-style="western"><surname>Beyer</surname><given-names>U.</given-names></name></person-group><article-title>Serum proteins as drug carriers of anticancer agents: A review</article-title><source>Drug Deliv.</source><year>1998</year><volume>5</volume><fpage>281</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.3109/10717549809065759</pub-id><pub-id pub-id-type="pmid">19569996</pub-id></element-citation></ref><ref id="B50-molecules-30-03461"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shiri</surname><given-names>F.</given-names></name><name name-style="western"><surname>Rahimi-Nasrabadi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ahmadi</surname><given-names>F.</given-names></name><name name-style="western"><surname>Ehrlich</surname><given-names>H.</given-names></name></person-group><article-title>Multispectroscopic and molecular modeling studies on the interaction of copper-ibuprofenate complex with bovine serum albumin (BSA)</article-title><source>Spectrochim. Acta A Mol. Biomol. Spectrosc.</source><year>2018</year><volume>203</volume><fpage>510</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1016/j.saa.2018.05.098</pub-id><pub-id pub-id-type="pmid">29902757</pub-id></element-citation></ref><ref id="B51-molecules-30-03461"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>R.</given-names></name><name name-style="western"><surname>Bian</surname><given-names>H.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><name name-style="western"><surname>He</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name><name name-style="western"><surname>Abdalla</surname><given-names>A.N.</given-names></name></person-group><article-title>Studies of Interactions between Beta-Cyfluthrin and BSA Based on Fluorescence Spectrometry and Ultraviolet Degradation</article-title><source>Photonics</source><year>2023</year><volume>10</volume><elocation-id>1079</elocation-id><pub-id pub-id-type="doi">10.3390/photonics10101079</pub-id></element-citation></ref><ref id="B52-molecules-30-03461"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>C.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name><name name-style="western"><surname>Li</surname><given-names>H.</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>W.</given-names></name><name name-style="western"><surname>Shi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L.</given-names></name><name name-style="western"><surname>Ji</surname><given-names>L.</given-names></name></person-group><article-title>Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes</article-title><source>J. Inorg. Biochem.</source><year>2008</year><volume>102</volume><fpage>347</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2007.09.008</pub-id><pub-id pub-id-type="pmid">18022241</pub-id></element-citation></ref><ref id="B53-molecules-30-03461"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Varlan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Hillebrand</surname><given-names>M.</given-names></name></person-group><article-title>Bovine and human serum albumin interactions with 3-carboxyphenoxathiin studied by fluorescence and circular dichroism spectroscopy</article-title><source>Molecules</source><year>2010</year><volume>15</volume><fpage>3905</fpage><lpage>3919</lpage><pub-id pub-id-type="doi">10.3390/molecules15063905</pub-id><pub-id pub-id-type="pmid">20657416</pub-id><pub-id pub-id-type="pmcid">PMC6257641</pub-id></element-citation></ref><ref id="B54-molecules-30-03461"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keikha</surname><given-names>A.O.</given-names></name><name name-style="western"><surname>Mansouri-Torshizi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Shahraki</surname><given-names>S.</given-names></name><name name-style="western"><surname>Dehghanian</surname><given-names>E.</given-names></name></person-group><article-title>Zn (II) and Pd (II) complexes derived from novel benzohydrazide-based Schiff base ligand as multi-target agents</article-title><source>J. Mol. Liq.</source><year>2023</year><volume>391</volume><fpage>123272</fpage><pub-id pub-id-type="doi">10.1016/j.molliq.2023.123272</pub-id></element-citation></ref><ref id="B55-molecules-30-03461"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obo&#328;ov&#225;</surname><given-names>B.</given-names></name><name name-style="western"><surname>Valentov&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liteck&#225;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pa&#353;kov&#225;</surname><given-names>&#317;.</given-names></name><name name-style="western"><surname>Hricov&#237;niov&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Bilkov&#225;</surname><given-names>A.</given-names></name><name name-style="western"><surname>Horv&#225;th</surname><given-names>B.</given-names></name><name name-style="western"><surname>Habala</surname><given-names>L.</given-names></name></person-group><article-title>Novel Copper (II) Complexes with Fluorine-Containing Reduced Schiff Base Ligands Showing Marked Cytotoxicity in the HepG2 Cancer Cell Line</article-title><source>Int. J. Mol. Sci.</source><year>2024</year><volume>25</volume><elocation-id>9166</elocation-id><pub-id pub-id-type="doi">10.3390/ijms25179166</pub-id><pub-id pub-id-type="pmid">39273115</pub-id><pub-id pub-id-type="pmcid">PMC11395566</pub-id></element-citation></ref><ref id="B56-molecules-30-03461"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>M.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Li</surname><given-names>X.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name></person-group><article-title>A comparative study of cytotoxicity and interaction with DNA/protein of five transition metal complexes with Schiff base ligands</article-title><source>J. Photochem. Photobiol. B.</source><year>2015</year><volume>148</volume><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2015.04.023</pub-id><pub-id pub-id-type="pmid">25974907</pub-id></element-citation></ref><ref id="B57-molecules-30-03461"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Yan</surname><given-names>H.</given-names></name><name name-style="western"><surname>Chang</surname><given-names>G.</given-names></name><name name-style="western"><surname>Hong</surname><given-names>M.</given-names></name><name name-style="western"><surname>Dou</surname><given-names>J.</given-names></name><name name-style="western"><surname>Niu</surname><given-names>M.</given-names></name></person-group><article-title>Cu(II), Ni(II) complexes derived from chiral Schiff-base ligands: Synthesis, characterization, cytotoxicity, protein and DNA&#8211;binding properties</article-title><source>J. Photochem. Photobiol. B</source><year>2016</year><volume>163</volume><fpage>403</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1016/j.jphotobiol.2016.09.005</pub-id><pub-id pub-id-type="pmid">27619741</pub-id></element-citation></ref><ref id="B58-molecules-30-03461"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alhazmi</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Al Bratty</surname><given-names>M.</given-names></name><name name-style="western"><surname>Meraya</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Najmi</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alam</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Javed</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Ahsan</surname><given-names>W.</given-names></name></person-group><article-title>Spectroscopic characterization of the interactions of bovine serum albumin with medicinally important metal ions: Platinum(IV), iridium(III) and iron(II)</article-title><source>Acta Biochim. Pol.</source><year>2021</year><volume>68</volume><fpage>99</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.18388/abp.2020_5462</pub-id><pub-id pub-id-type="pmid">33596034</pub-id></element-citation></ref><ref id="B59-molecules-30-03461"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shahabadi</surname><given-names>N.</given-names></name><name name-style="western"><surname>Hakimi</surname><given-names>M.</given-names></name><name name-style="western"><surname>Morovati</surname><given-names>T.</given-names></name><name name-style="western"><surname>Hadidi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Moeini</surname><given-names>K.</given-names></name></person-group><article-title>Spectroscopic investigation into the interaction of a diazacyclam-based macrocyclic copper (ii) complex with bovine serum albumin</article-title><source>Luminescence</source><year>2017</year><volume>32</volume><fpage>43</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/bio.3146</pub-id><pub-id pub-id-type="pmid">27162056</pub-id></element-citation></ref><ref id="B60-molecules-30-03461"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y.Z.</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X.P.</given-names></name><name name-style="western"><surname>Hou</surname><given-names>H.N.</given-names></name><name name-style="western"><surname>Dai</surname><given-names>J.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name></person-group><article-title>Study on the interaction between Cu phen2+3 and bovine serum albumin by spectroscopic methods</article-title><source>Biol. Trace Elem. Res.</source><year>2008</year><volume>121</volume><fpage>276</fpage><lpage>287</lpage><pub-id pub-id-type="doi">10.1007/s12011-007-8045-z</pub-id><pub-id pub-id-type="pmid">17960331</pub-id></element-citation></ref><ref id="B61-molecules-30-03461"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smolkov&#225;</surname><given-names>R.</given-names></name><name name-style="western"><surname>Smolko</surname><given-names>L.</given-names></name><name name-style="western"><surname>Samo&#318;ov&#225;</surname><given-names>E.</given-names></name><name name-style="western"><surname>Du&#353;ek</surname><given-names>M.</given-names></name></person-group><article-title>Co(II) fenamato, tolfenamato and niflumato complexes with neocuproine: Synthesis, crystal structure, spectral characterization and biological activity</article-title><source>J. Mol. Struct.</source><year>2023</year><volume>1272</volume><fpage>134172</fpage><pub-id pub-id-type="doi">10.1016/j.molstruc.2022.134172</pub-id></element-citation></ref><ref id="B62-molecules-30-03461"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bitacura</surname><given-names>J.G.</given-names></name></person-group><article-title>The Use of Baker&#8217;s Yeast in the Resazurin Reduction Test: A Simple, Low-Cost Method for Determining Cell Viability in Proliferation and Cytotoxicity Assays</article-title><source>J. Microbiol. Biol. Educ.</source><year>2018</year><volume>19</volume><fpage>19</fpage><lpage>87</lpage><pub-id pub-id-type="doi">10.1128/jmbe.v19i2.1599</pub-id><pub-id pub-id-type="pmcid">PMC6113665</pub-id><pub-id pub-id-type="pmid">30197729</pub-id></element-citation></ref><ref id="B63-molecules-30-03461"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botstein</surname><given-names>D.</given-names></name><name name-style="western"><surname>Chervitz</surname><given-names>S.A.</given-names></name><name name-style="western"><surname>Cherry</surname><given-names>J.M.</given-names></name></person-group><article-title>Yeast as a model organism</article-title><source>Science</source><year>1997</year><volume>277</volume><fpage>1259</fpage><lpage>1260</lpage><pub-id pub-id-type="doi">10.1126/science.277.5330.1259</pub-id><pub-id pub-id-type="pmid">9297238</pub-id><pub-id pub-id-type="pmcid">PMC3039837</pub-id></element-citation></ref><ref id="B64-molecules-30-03461"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Botstein</surname><given-names>D.</given-names></name><name name-style="western"><surname>Fink</surname><given-names>G.R.</given-names></name></person-group><article-title>Yeast: An experimental organism for 21st century biology</article-title><source>Genetics</source><year>2011</year><volume>189</volume><fpage>695</fpage><lpage>704</lpage><pub-id pub-id-type="doi">10.1534/genetics.111.130765</pub-id><pub-id pub-id-type="pmid">22084421</pub-id><pub-id pub-id-type="pmcid">PMC3213361</pub-id></element-citation></ref><ref id="B65-molecules-30-03461"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matuo</surname><given-names>R.</given-names></name><name name-style="western"><surname>Sousa</surname><given-names>F.G.</given-names></name><name name-style="western"><surname>Soares</surname><given-names>D.G.</given-names></name><name name-style="western"><surname>Bonatto</surname><given-names>D.</given-names></name><name name-style="western"><surname>Saffi</surname><given-names>J.</given-names></name><name name-style="western"><surname>Escargueil</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>A.K.</given-names></name><name name-style="western"><surname>Henriques</surname><given-names>J.A.</given-names></name></person-group><article-title>Saccharomyces cerevisiae as a model system to study the response to anticancer agents</article-title><source>Cancer Chemother. Pharmacol.</source><year>2012</year><volume>70</volume><fpage>491</fpage><lpage>502</lpage><pub-id pub-id-type="doi">10.1007/s00280-012-1937-4</pub-id><pub-id pub-id-type="pmid">22851206</pub-id></element-citation></ref><ref id="B66-molecules-30-03461"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tr&#225;vn&#237;&#269;ek</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Van&#269;o</surname><given-names>J.</given-names></name><name name-style="western"><surname>Belza</surname><given-names>J.</given-names></name><name name-style="western"><surname>Zoppellaro</surname><given-names>G.</given-names></name><name name-style="western"><surname>Dvo&#345;&#225;k</surname><given-names>Z.</given-names></name></person-group><article-title>Dinuclear copper(II) complexes with a bridging bis(chalcone) ligand reveal considerable in vitro cytotoxicity on human cancer cells and enhanced selectivity</article-title><source>J. Inorg. Biochem.</source><year>2024</year><volume>252</volume><elocation-id>112481</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2024.112481</pub-id><pub-id pub-id-type="pmid">38215536</pub-id></element-citation></ref><ref id="B67-molecules-30-03461"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yenigun</surname><given-names>V.B.</given-names></name><name name-style="western"><surname>Kocyigit</surname><given-names>A.</given-names></name><name name-style="western"><surname>Kanimdan</surname><given-names>E.</given-names></name><name name-style="western"><surname>Balkan</surname><given-names>E.</given-names></name><name name-style="western"><surname>Gul</surname><given-names>A.Z.</given-names></name></person-group><article-title>Copper (II) increases anti-Proliferative activity of thymoquinone in colon cancer cells by increasing genotoxic, apoptotic, and reactive oxygen species generating effects</article-title><source>Toxicon</source><year>2024</year><volume>250</volume><fpage>108103</fpage><pub-id pub-id-type="doi">10.1016/j.toxicon.2024.108103</pub-id><pub-id pub-id-type="pmid">39278473</pub-id></element-citation></ref><ref id="B68-molecules-30-03461"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name></person-group><article-title>Copper homeostasis and copper-induced cell death: Novel targeting for intervention in the pathogenesis of vascular aging</article-title><source>Biomed. Pharmacother.</source><year>2023</year><volume>169</volume><elocation-id>115839</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2023.115839</pub-id><pub-id pub-id-type="pmid">37976889</pub-id></element-citation></ref><ref id="B69-molecules-30-03461"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X.</given-names></name><name name-style="western"><surname>Tao</surname><given-names>T.</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name></person-group><article-title>Copper-mediated novel cell death pathway in tumor cells and implications for innovative cancer therapies</article-title><source>Biomed. Pharmacother.</source><year>2023</year><volume>168</volume><elocation-id>115730</elocation-id><pub-id pub-id-type="doi">10.1016/j.biopha.2023.115730</pub-id><pub-id pub-id-type="pmid">37864891</pub-id></element-citation></ref><ref id="B70-molecules-30-03461"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghorbanpour</surname><given-names>M.</given-names></name><name name-style="western"><surname>Shayanfar</surname><given-names>A.</given-names></name><name name-style="western"><surname>Soltani</surname><given-names>B.</given-names></name></person-group><article-title>Copper pyrazole complexes as potential anticancer agents: Evaluation of cytotoxic response against cancer cells and their mechanistic action at the molecular level</article-title><source>Coord. Chem. Rev.</source><year>2024</year><volume>498</volume><fpage>215459</fpage><pub-id pub-id-type="doi">10.1016/j.ccr.2023.215459</pub-id></element-citation></ref><ref id="B71-molecules-30-03461"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dolomanov</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bouhris</surname><given-names>O.V.</given-names></name><name name-style="western"><surname>Gildea</surname><given-names>L.J.</given-names></name><name name-style="western"><surname>Howard</surname><given-names>R.J.</given-names></name><name name-style="western"><surname>Puschmann</surname><given-names>J.A.K.</given-names></name></person-group><article-title>OLEX 2: A complete structure solution, refinement and analysis program</article-title><source>J. Appl. Cryst.</source><year>2009</year><volume>42</volume><fpage>339</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1107/S0021889808042726</pub-id></element-citation></ref><ref id="B72-molecules-30-03461"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheldrick</surname><given-names>G.M.</given-names></name></person-group><article-title>SHELXT-Integrated space-group and crystal-structure determination</article-title><source>Acta Crystallogr. A Found. Adv.</source><year>2015</year><volume>71</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1107/S2053273314026370</pub-id><pub-id pub-id-type="pmid">25537383</pub-id><pub-id pub-id-type="pmcid">PMC4283466</pub-id></element-citation></ref><ref id="B73-molecules-30-03461"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheldrick</surname><given-names>G.M.</given-names></name></person-group><article-title>Crystal structure refinement with SHELXL</article-title><source>Acta Crystallogr. C Struct. Chem.</source><year>2015</year><volume>71</volume><fpage>3</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1107/S2053229614024218</pub-id><pub-id pub-id-type="pmid">25567568</pub-id><pub-id pub-id-type="pmcid">PMC4294323</pub-id></element-citation></ref><ref id="B74-molecules-30-03461"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bergerhoff</surname><given-names>G.</given-names></name><name name-style="western"><surname>Berndt</surname><given-names>M.</given-names></name><name name-style="western"><surname>Brandenburg</surname><given-names>K.</given-names></name></person-group><article-title>Crystallographic Data with the Program DIAMOND</article-title><source>J. Res. Natl. Inst. Stand. Technol.</source><year>1996</year><volume>101</volume><fpage>221</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.6028/jres.101.023</pub-id><pub-id pub-id-type="pmid">27805159</pub-id><pub-id pub-id-type="pmcid">PMC4963142</pub-id></element-citation></ref><ref id="B75-molecules-30-03461"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macrae</surname><given-names>C.F.</given-names></name><name name-style="western"><surname>Edgington</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>McCabe</surname><given-names>P.</given-names></name><name name-style="western"><surname>Pidcock</surname><given-names>E.</given-names></name><name name-style="western"><surname>Shields</surname><given-names>G.P.</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>R.</given-names></name><name name-style="western"><surname>Towler</surname><given-names>M.</given-names></name><name name-style="western"><surname>van de Streek</surname><given-names>J.</given-names></name></person-group><article-title>Mercury: Visualization and analysis of crystal structures</article-title><source>J. Appl. Cryst.</source><year>2006</year><volume>39</volume><fpage>453</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1107/S002188980600731X</pub-id></element-citation></ref><ref id="B76-molecules-30-03461"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoll</surname><given-names>S.</given-names></name><name name-style="western"><surname>Schweiger</surname><given-names>A.</given-names></name></person-group><article-title>EasySpin, a comprehensive software package for spectral simulation and analysis in EPR</article-title><source>J. Magn. Reson.</source><year>2006</year><volume>178</volume><fpage>42</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1016/j.jmr.2005.08.013</pub-id><pub-id pub-id-type="pmid">16188474</pub-id></element-citation></ref><ref id="B77-molecules-30-03461"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stoll</surname><given-names>S.</given-names></name></person-group><article-title>CW-EPR Spectral Simulations: Solid State</article-title><source>Methods Enzymol.</source><year>2015</year><volume>563</volume><fpage>121</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1016/bs.mie.2015.06.003</pub-id><pub-id pub-id-type="pmid">26478484</pub-id></element-citation></ref><ref id="B78-molecules-30-03461"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Molton</surname><given-names>F.</given-names></name></person-group><article-title>Simultispin: A versatile graphical user interface for the simulation of solid-state continuous wave EPR spectra</article-title><source>Magn. Reson. Chem.</source><year>2020</year><volume>58</volume><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1002/mrc.5019</pub-id><pub-id pub-id-type="pmid">32173891</pub-id></element-citation></ref><ref id="B79-molecules-30-03461"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Green</surname><given-names>M.R.</given-names></name><name name-style="western"><surname>Sambrook</surname><given-names>J.</given-names></name></person-group><article-title>Agarose gel electrophoresis</article-title><source>Cold Spring Harbor Protoc.</source><year>2019</year><pub-id pub-id-type="doi">10.1101/pdb.prot100404</pub-id><pub-id pub-id-type="pmid">30602560</pub-id></element-citation></ref><ref id="B80-molecules-30-03461"><label>80.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>T.</given-names></name><name name-style="western"><surname>Friehs</surname><given-names>K.</given-names></name><name name-style="western"><surname>Flaschel</surname><given-names>E.</given-names></name></person-group><article-title>Chapter 2: Structures of plasmid DNA</article-title><source>Plasmids for Therapy and Vaccination</source><person-group person-group-type="editor"><name name-style="western"><surname>Schleef</surname><given-names>M.</given-names></name></person-group><publisher-name>WILEY-VCH Verlag GmbH</publisher-name><publisher-loc>Weinheim, Germany</publisher-loc><year>2001</year><fpage>29</fpage><lpage>43</lpage><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://onlinelibrary.wiley.com/doi/book/10.1002/9783527612833" ext-link-type="uri">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527612833</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-04-26">(accessed on 26 April 2023)</date-in-citation></element-citation></ref><ref id="B81-molecules-30-03461"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jozef&#237;kov&#225;</surname><given-names>F.</given-names></name><name name-style="western"><surname>Perontsis</surname><given-names>S.</given-names></name><name name-style="western"><surname>Ko&#328;&#225;rikov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>&#352;vorc</surname><given-names>&#317;.</given-names></name><name name-style="western"><surname>Maz&#250;r</surname><given-names>M.</given-names></name><name name-style="western"><surname>Psomas</surname><given-names>G.</given-names></name><name name-style="western"><surname>Moncol</surname><given-names>J.</given-names></name></person-group><article-title>In vitro biological activity of copper (II) complexes with NSAIDs and nicotinamide: Characterization, DNA-and BSA-interaction study and anticancer activity</article-title><source>J. Inor. Biochem.</source><year>2022</year><volume>228</volume><elocation-id>111696</elocation-id><pub-id pub-id-type="doi">10.1016/j.jinorgbio.2021.111696</pub-id><pub-id pub-id-type="pmid">35030390</pub-id></element-citation></ref><ref id="B82-molecules-30-03461"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D.</given-names></name></person-group><article-title>A rapid biochemical test for measuring chemical toxicity</article-title><source>Bull. Environ. Contam. Toxicol.</source><year>1981</year><volume>26</volume><fpage>145</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1007/BF01622068</pub-id><pub-id pub-id-type="pmid">7248535</pub-id></element-citation></ref><ref id="B83-molecules-30-03461"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piro&#353;</surname><given-names>M.</given-names></name><name name-style="western"><surname>Schoeller</surname><given-names>M.</given-names></name><name name-style="western"><surname>Ko&#328;&#225;rikov&#225;</surname><given-names>K.</given-names></name><name name-style="western"><surname>Sumbalov&#225;</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Valentov&#225;</surname><given-names>J.</given-names></name><name name-style="western"><surname>Monco&#318;</surname><given-names>J.</given-names></name><name name-style="western"><surname>May</surname><given-names>N.V.</given-names></name><name name-style="western"><surname>Pap</surname><given-names>J.S.</given-names></name><name name-style="western"><surname>&#352;vorec</surname><given-names>J.</given-names></name></person-group><article-title>Synthesis, characterization and biological evaluation of three novel copper (II) clonixinate complexes with methylpyridines: Insights into structure, DNA and BSA binding properties and anticancer activity</article-title><source>Polyhedron.</source><year>2023</year><volume>245</volume><fpage>116619</fpage><pub-id pub-id-type="doi">10.1016/j.poly.2023.116619</pub-id></element-citation></ref><ref id="B84-molecules-30-03461"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Strotmann</surname><given-names>U.J.</given-names></name><name name-style="western"><surname>Butz</surname><given-names>B.</given-names></name><name name-style="western"><surname>Bias</surname><given-names>W.R.</given-names></name></person-group><article-title>The dehydrogenase assay with resazurin: Practical performance as a monitoring system and pH-dependent toxicity of phenolic compounds</article-title><source>Ecotoxicol. Environ. Saf.</source><year>1993</year><volume>25</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1006/eesa.1993.1009</pub-id><pub-id pub-id-type="pmid">7682921</pub-id></element-citation></ref><ref id="B85-molecules-30-03461"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Candeias</surname><given-names>L.P.</given-names></name><name name-style="western"><surname>MacFarlane</surname><given-names>D.P.S.</given-names></name><name name-style="western"><surname>McWhinnie</surname><given-names>S.L.W.</given-names></name><name name-style="western"><surname>Maidwell</surname><given-names>N.L.</given-names></name><name name-style="western"><surname>Roesechlaub</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Sammes</surname><given-names>P.G.</given-names></name><name name-style="western"><surname>Whittlesey</surname><given-names>R.</given-names></name></person-group><article-title>The catalyzed NADH reduction of resazurin to resorufin</article-title><source>J. Chem. Soc. Perkin Trans.</source><year>1998</year><volume>2</volume><fpage>2333</fpage><lpage>2334</lpage><pub-id pub-id-type="doi">10.1039/a806431h</pub-id></element-citation></ref><ref id="B86-molecules-30-03461"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borra</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Lotufo</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Gagioti</surname><given-names>S.M.</given-names></name><name name-style="western"><surname>Barros</surname><given-names>F.D.M.</given-names></name><name name-style="western"><surname>Andrade</surname><given-names>P.M.</given-names></name></person-group><article-title>A simple method to measure cell viability in proliferation and cytotoxicity assays</article-title><source>Braz. Oral Res.</source><year>2009</year><volume>23</volume><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1590/S1806-83242009000300006</pub-id><pub-id pub-id-type="pmid">19893959</pub-id></element-citation></ref><ref id="B87-molecules-30-03461"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lavogina</surname><given-names>D.</given-names></name><name name-style="western"><surname>Lust</surname><given-names>H.</given-names></name><name name-style="western"><surname>Tahk</surname><given-names>M.J.</given-names></name><name name-style="western"><surname>Laasfeld</surname><given-names>T.</given-names></name><name name-style="western"><surname>Vellama</surname><given-names>H.</given-names></name><name name-style="western"><surname>Nasirova</surname><given-names>N.</given-names></name><name name-style="western"><surname>Vardja</surname><given-names>M.</given-names></name><name name-style="western"><surname>Eskla</surname><given-names>K.L.</given-names></name><name name-style="western"><surname>Salumets</surname><given-names>A.</given-names></name><name name-style="western"><surname>Rinken</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Revisiting the Resazurin-Based Sensing of Cellular Viability: Widening the Application Horizon</article-title><source>Biosensors</source><year>2022</year><volume>12</volume><elocation-id>196</elocation-id><pub-id pub-id-type="doi">10.3390/bios12040196</pub-id><pub-id pub-id-type="pmid">35448256</pub-id><pub-id pub-id-type="pmcid">PMC9032648</pub-id></element-citation></ref><ref id="B88-molecules-30-03461"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosmann</surname><given-names>T.</given-names></name></person-group><article-title>Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays</article-title><source>J. Immunol. Methods</source><year>1983</year><volume>65</volume><fpage>55</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1016/0022-1759(83)90303-4</pub-id><pub-id pub-id-type="pmid">6606682</pub-id></element-citation></ref></ref-list><sec sec-type="display-objects"><title>Figures, Schemes and Tables</title><fig position="float" id="molecules-30-03461-sch001" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-sch001_Scheme 1</object-id><label>Scheme 1</label><caption><p>Overall synthesis of Schiff bases <bold>3a-c</bold> and their copper(II) complexes <bold>4a</bold>&#8211;<bold>c</bold> (<bold>a</bold>: 2-methoxy-, <bold>b</bold>: 3-methoxy-, <bold>c</bold>: 4-methoxyderivative).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-sch001.jpg"/></fig><fig position="float" id="molecules-30-03461-f001" orientation="portrait"><label>Figure 1</label><caption><p>The molecular structure (as two dimer molecules) of complex <bold>4a</bold> showing the atom-labeling scheme without hydrogen atom labels for clarity. Displacement ellipsoids are drawn at the 50% probability level.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g001.jpg"/></fig><fig position="float" id="molecules-30-03461-f002" orientation="portrait"><label>Figure 2</label><caption><p>Solid-state powder EPR spectra of <bold>4a</bold>&#8211;<bold>c</bold> at 300 K (red line) and at 77 K (black line).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g002.jpg"/></fig><fig position="float" id="molecules-30-03461-f003" orientation="portrait"><label>Figure 3</label><caption><p>UV&#8211;Vis spectra of DMSO solution of complex <bold>4a</bold> in the absence (dashed line) and presence (solid line) of increasing amounts of ct-DNA (<italic toggle="yes">r</italic> = [DNA]/[complex] = 0&#8211;2.1). Arrows show changes in intensity upon the addition of increasing amounts of ct-DNA. Insert: Plot of [DNA]/&#949;<sub>A</sub>-&#949;<sub>f</sub>&#160;vs. [DNA] for complex.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g003.jpg"/></fig><fig position="float" id="molecules-30-03461-f004" orientation="portrait"><label>Figure 4</label><caption><p>Closely related published DNA binders and their binding modes [<xref rid="B32-molecules-30-03461" ref-type="bibr">32</xref>,<xref rid="B33-molecules-30-03461" ref-type="bibr">33</xref>,<xref rid="B34-molecules-30-03461" ref-type="bibr">34</xref>].</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g004.jpg"/></fig><fig position="float" id="molecules-30-03461-f005" orientation="portrait"><label>Figure 5</label><caption><p>(<bold>A</bold>) Emission fluorescence spectra of EB&#8211;DNA in buffer solution in the presence of an increasing amount of complex <bold>4a</bold>. The concentration of the added complexes ranged from 0 to 0.16 mM (concentration increase 1.6 &#215; 10<sup>&#8722;2</sup> mM, indicated by a different color of the curve). The arrows indicate changes in fluorescence at increasing amounts of the complex. The insert graph shows the plot of I/I<sub>0</sub> vs [complex]. (<bold>B</bold>) Plot of EB&#8211;DNA relative fluorescence intensity (I/I<sub>0</sub>), % at &#955; = 614 nm versus concentration ratio [complex]/[EB&#8211;DNA] for <bold>4a</bold>&#8211;<bold>c</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g005.jpg"/></fig><fig position="float" id="molecules-30-03461-f006" orientation="portrait"><label>Figure 6</label><caption><p>Relative viscosity of DNA in the buffer solution in the presence of studied complexes <bold>4a</bold>&#8211;<bold>c</bold> under the condition of increasing the concentration ratio [complex]/[DNA]; [DNA] = 100 &#181;M, [complex] = 0&#8211;22 &#181;M.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g006.jpg"/></fig><fig position="float" id="molecules-30-03461-f007" orientation="portrait"><label>Figure 7</label><caption><p>Agarose gel electrophoresis patterns of cleavage of the pBR322 DNA plasmid by copper complexes. <bold>Line 1</bold>&#8212;control (undigested DNA plasmid), <bold>Line 2</bold>&#8212;DNA plasmid digested with copper complex at concentration of 1 mM, <bold>Line 3</bold>&#8212;at concentration of 3 m M, <bold>Line 4</bold>&#8212;at concentration of 5 mM. <bold>Form I</bold>&#8212;supercoiled plasmid DNA (undigested plasmid), <bold>Form II</bold>&#8212;open-circular plasmid DNA (partly digested plasmid), <bold>Form III</bold>&#8212;linear plasmid DNA (completely digested plasmid).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g007.jpg"/></fig><fig position="float" id="molecules-30-03461-f008" orientation="portrait"><label>Figure 8</label><caption><p>(<bold>A</bold>) Fluorescence emission spectra of BSA in buffer solution in the presence of increasing concentrations of complex <bold>4a</bold>. The arrow indicates changes in fluorescence with increasing amounts of the complex. The concentration of the added complexes ranged from 0 to 1.6 &#215; 10<sup>&#8722;2</sup> mM (the concentration increment was 1.6 &#215; 10<sup>&#8722;3</sup> mM). (<bold>B</bold>) Graphical dependence of relative BSA fluorescence intensity in % at <italic toggle="yes">&#955;</italic> = 336 nm vs. concentration ratio [complex]/BSA for complexes <bold>4a</bold>&#8211;<bold>c</bold>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g008.jpg"/></fig><fig position="float" id="molecules-30-03461-f009" orientation="portrait"><label>Figure 9</label><caption><p>IC<sub>50</sub> concentrations for cytotoxicity against cancer cells A549 and HepG2 and noncancerous HEL cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-g009.jpg"/></fig><fig position="float" id="molecules-30-03461-sch002" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-sch002_Scheme 2</object-id><label>Scheme 2</label><caption><p>Conversion of resazurin to resorufin in the mitochondria of living cells.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="molecules-30-03461-sch002.jpg"/></fig><table-wrap position="float" id="molecules-30-03461-t001" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t001_Table 1</object-id><label>Table 1</label><caption><p>Crystal data and structure refinement for complex <bold>4a</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Empirical Formula</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">C<sub>30</sub>H<sub>28</sub>Cl<sub>2</sub>Cu<sub>2</sub>N<sub>2</sub>O<sub>4</sub></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Temperature [K]</td><td align="center" valign="middle" rowspan="1" colspan="1">100(1)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Wavelength [&#197;]</td><td align="center" valign="middle" rowspan="1" colspan="1">1.54186</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Crystal system</td><td align="center" valign="middle" rowspan="1" colspan="1">Monoclinic</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Space group</td><td align="center" valign="middle" rowspan="1" colspan="1">P2<sub>1</sub>/c</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Unit cell dimensions [&#197;], [&#176;] </td><td align="center" valign="middle" rowspan="1" colspan="1">a = 9.2198(1)<break/>b = 17.4213(3)<break/>c = 17.4576(2)<break/>&#946; = 92.412(1)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Formula weight</td><td align="center" valign="middle" rowspan="1" colspan="1">678.52</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Volume [&#197;<sup>3</sup>]</td><td align="center" valign="middle" rowspan="1" colspan="1">2801.57(7)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Z/Calculated density [Mg/m<sup>3</sup>]</td><td align="center" valign="middle" rowspan="1" colspan="1">4/1.609</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Absorption coeff. [mm<sup>&#8722;1</sup>]</td><td align="center" valign="middle" rowspan="1" colspan="1">3.955</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">F(000)</td><td align="center" valign="middle" rowspan="1" colspan="1">1384.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Crystal size [mm]</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2 &#215; 0.04 &#215; 0.02</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Theta range for data collection</td><td align="center" valign="middle" rowspan="1" colspan="1">7.172 to 143.116&#176;</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Index ranges</td><td align="center" valign="middle" rowspan="1" colspan="1">&#8722;11 &#8804; h &#8804; 5<break/>&#8722;20 &#8804; k &#8804; 21 <break/>&#8722;21 &#8804; l &#8804; 21</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Reflections collected/<break/>Independent reflections</td><td align="center" valign="middle" rowspan="1" colspan="1">83,351/5393 <break/>[R<sub>(int)</sub> = 0.0325, R<sub>&#963;</sub> = 0.0166]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Refinement method</td><td align="center" valign="middle" rowspan="1" colspan="1">Full-matrix least-squares on F<sup>2</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Data/restraints/parameters</td><td align="center" valign="middle" rowspan="1" colspan="1">5393/0/363</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Goodness-of-fit on F<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.088</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Final R indices [I &gt; 2&#963;(I)]</td><td align="center" valign="middle" rowspan="1" colspan="1">R<sub>1</sub> = 0.0259, <break/>wR<sub>2</sub> = 0.0775</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">R indices (all data)</td><td align="center" valign="middle" rowspan="1" colspan="1">R<sub>1</sub> = 0.0303, <break/>wR<sub>2</sub> = 0.0791</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Largest diff. peak and hole [e.&#197;&#8722;3]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.36/&#8722;0.55</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03461-t002" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t002_Table 2</object-id><label>Table 2</label><caption><p>Selected bond lengths and angles for complex <bold>4a</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Atom</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Atom</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Length/&#197;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Atom</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Atom</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Length/&#197;</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0485(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">3.0501(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl1</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1975(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl2</td><td align="center" valign="middle" rowspan="1" colspan="1">2.1946(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9435(12)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9433(15)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">O1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9650(12)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">1.9304(13)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9374(15)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">O3 **</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9671(12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Atom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Atom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Atom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Angle/&#730;</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Atom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Atom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Atom</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>Angle/&#730;</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cl1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">132.188(19)</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">131.859(19)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">38.99(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">127.18(4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">38.49(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl2</td><td align="center" valign="middle" rowspan="1" colspan="1">100.23(5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl1</td><td align="center" valign="middle" rowspan="1" colspan="1">99.93(4)</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">O3 **</td><td align="center" valign="middle" rowspan="1" colspan="1">154.41(6)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl1</td><td align="center" valign="middle" rowspan="1" colspan="1">151.53(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">O3 **</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">38.07(4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">O1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">77.48(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">38.93(3)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">127.56(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">O3 **</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl2</td><td align="center" valign="middle" rowspan="1" colspan="1">100.51(4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl1</td><td align="center" valign="middle" rowspan="1" colspan="1">99.65(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cl2</td><td align="center" valign="middle" rowspan="1" colspan="1">150.29(4)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">O1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">155.18(6)</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">92.05(6)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">92.20(6)</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">O3 **</td><td align="center" valign="middle" rowspan="1" colspan="1">77.00(5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">102.51(5)</td><td align="center" valign="middle" rowspan="1" colspan="1">C16</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">116.84(11)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C14</td><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1 *</td><td align="center" valign="middle" rowspan="1" colspan="1">132.25(11)</td><td align="center" valign="middle" rowspan="1" colspan="1">C23</td><td align="center" valign="middle" rowspan="1" colspan="1">N2</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">124.35(13)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C14</td><td align="center" valign="middle" rowspan="1" colspan="1">O1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">124.25(11)</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">103.00(5)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">C1</td><td align="center" valign="middle" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" rowspan="1" colspan="1">118.54(12)</td><td align="center" valign="middle" rowspan="1" colspan="1">C29</td><td align="center" valign="middle" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" rowspan="1" colspan="1">Cu2 **</td><td align="center" valign="middle" rowspan="1" colspan="1">132.17(11)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cu1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123.93(13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">C29</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">O3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cu2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">123.37(11)</td></tr></tbody></table><table-wrap-foot><fn><p>Symmetry transformations used to generate equivalent atoms: * 1-x,1-y,-z; ** 2-x,1-y,1-z.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="molecules-30-03461-t003" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t003_Table 3</object-id><label>Table 3</label><caption><p>UV&#8211;Vis spectral data of the interaction with ct-DNA, calculated DNA-binding constants (K<italic toggle="yes"><sub>b</sub></italic>), UV band <italic toggle="yes">&#955;</italic> (nm) and decrease of intensity (&#916;A/A<sub>0</sub>) in %.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Complex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">K<sub>b</sub> [M<sup>&#8722;1</sup>]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#955; (nm)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">(&#916;A/A<sub>0</sub>, %)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4a</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.43 (&#177;0.84) &#215; 10<sup>5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">369</td><td align="center" valign="middle" rowspan="1" colspan="1">32</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4b</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.02 (&#177;0.82) &#215; 10<sup>5</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">369</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4c</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.25 (&#177;0.83) &#215; 10<sup>5</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">370</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03461-t004" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t004_Table 4</object-id><label>Table 4</label><caption><p>EB&#8211;DNA fluorescence (%), calculated Stern&#8211;Volmer quenching constant (<italic toggle="yes">K<sub>sv</sub></italic>) and quenching rate constant <italic toggle="yes">k<sub>q</sub></italic> of complexes <bold>4a</bold>&#8211;<bold>c</bold>.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Complex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#916; I/I<sub>0</sub> [%]</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">K<sub>sv</sub></italic> [M<sup>&#8722;1</sup>] &#215; 10<sup>3</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">k<sub>q</sub></italic> [M<sup>&#8722;1</sup> s<sup>&#8722;1</sup>] &#215; 10<sup>11</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4a</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">45.7</td><td align="center" valign="middle" rowspan="1" colspan="1">4.58 (&#177;0.10)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.98 (&#177;0.05)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4b</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">40.1</td><td align="center" valign="middle" rowspan="1" colspan="1">3.61 (&#177;0.09)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56 (&#177;0.04)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4c</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.82 (&#177;0.12)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.66 (&#177;0.05)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03461-t005" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t005_Table 5</object-id><label>Table 5</label><caption><p>Quantitative evaluation of the nuclease activity of copper(II) complexes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Complex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">c (M)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Form I (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Form II (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Form III (%)</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>4a</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">90.7</td><td align="center" valign="middle" rowspan="1" colspan="1">9.7</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">58.8</td><td align="center" valign="middle" rowspan="1" colspan="1">41.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">53.8</td><td align="center" valign="middle" rowspan="1" colspan="1">46.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">100</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>4b</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">89.7</td><td align="center" valign="middle" rowspan="1" colspan="1">10.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">58.5</td><td align="center" valign="middle" rowspan="1" colspan="1">41.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">56.2</td><td align="center" valign="middle" rowspan="1" colspan="1">43.8</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr><tr><td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
<bold>4c</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">93.6</td><td align="center" valign="middle" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">1 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">49.8</td><td align="center" valign="middle" rowspan="1" colspan="1">50.2</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">3 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">0</td><td align="center" valign="middle" rowspan="1" colspan="1">100</td><td align="center" valign="middle" rowspan="1" colspan="1">0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 &#215; 10<sup>&#8722;3</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03461-t006" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t006_Table 6</object-id><label>Table 6</label><caption><p>The values of the dynamic quenching constant (<italic toggle="yes">K<sub>sv</sub></italic>), quenching constant (<italic toggle="yes">k</italic><sub>q</sub>) association binding constant (<italic toggle="yes">K<sub>BSA</sub></italic>) and <italic toggle="yes">n</italic> (number of binding sites for albumin) obtained for the interaction of <bold>4a</bold>&#8211;<bold>c</bold> with bovine serum albumin.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Complex</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">K<sub>sv</sub> (M<sup>&#8722;1</sup>) &#215; 10<sup>4</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">k<sub>q</sub> (M<sup>&#8722;1</sup>s<sup>&#8722;1</sup>) &#215; 10<sup>12</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">K<sub>BSA</sub> (M<sup>&#8722;1</sup>) &#215; 10<sup>4</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">n</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4a</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">7.16 (&#177;0.03) </td><td align="center" valign="middle" rowspan="1" colspan="1">7.16 (&#177;0.03) </td><td align="center" valign="middle" rowspan="1" colspan="1">6.66 (&#177;0.30) </td><td align="center" valign="middle" rowspan="1" colspan="1">1.03</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4b</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">6.39 (&#177;0.06) </td><td align="center" valign="middle" rowspan="1" colspan="1">6.39 (&#177;0.06) </td><td align="center" valign="middle" rowspan="1" colspan="1">5.37 (&#177;0.25) </td><td align="center" valign="middle" rowspan="1" colspan="1">0.94</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4c</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.86 (&#177;0.15) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.86 (&#177;0.15) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.77 (&#177;0.20) </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.16</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03461-t007" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t007_Table 7</object-id><label>Table 7</label><caption><p>Absorbance values for 570 nm and 600 nm, along with the calculated reduction percentage.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sample</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Absorbance *<break/>570 nm</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Absorbance *<break/>600 nm</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reduction Percentage (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Cell Death (%)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Positive control C+</td><td align="center" valign="middle" rowspan="1" colspan="1">1.10</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">88.6</td><td align="center" valign="middle" rowspan="1" colspan="1">12.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Negative control C&#8722;</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.69</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.93</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4a</bold> (1 mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.55</td><td align="center" valign="middle" rowspan="1" colspan="1">0.25</td><td align="center" valign="middle" rowspan="1" colspan="1">32.9</td><td align="center" valign="middle" rowspan="1" colspan="1">67.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4a</bold> (3 mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.44</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">8.4</td><td align="center" valign="middle" rowspan="1" colspan="1">91.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>4a</bold> (5 mM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">96.5</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4b</bold> (1 mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.75</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69</td><td align="center" valign="middle" rowspan="1" colspan="1">24.0</td><td align="center" valign="middle" rowspan="1" colspan="1">76.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4b</bold> (3 mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69</td><td align="center" valign="middle" rowspan="1" colspan="1">0.88</td><td align="center" valign="middle" rowspan="1" colspan="1">7.4</td><td align="center" valign="middle" rowspan="1" colspan="1">92.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>4b</bold> (5 mM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">99.0</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4c</bold> (1 mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.60</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77</td><td align="center" valign="middle" rowspan="1" colspan="1">5.2</td><td align="center" valign="middle" rowspan="1" colspan="1">94.8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>4c</bold> (3 mM)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.40</td><td align="center" valign="middle" rowspan="1" colspan="1">0.44</td><td align="center" valign="middle" rowspan="1" colspan="1">8.5</td><td align="center" valign="middle" rowspan="1" colspan="1">91.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><bold>4c</bold> (5 mM)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">97.4</td></tr></tbody></table><table-wrap-foot><fn><p>* Average of 3 measurements.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="molecules-30-03461-t008" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t008_Table 8</object-id><label>Table 8</label><caption><p>IC<sub>50</sub> values (&#956;M) against A549 and HepG2 cancer cells and HEL fibroblasts.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub>&#8212;A549</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub>&#8212;HepG2</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">IC<sub>50</sub>&#8212;HEL</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4a</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">66.4 &#177; 6.2</td><td align="center" valign="middle" rowspan="1" colspan="1">17.9 &#177; 2.6</td><td align="center" valign="middle" rowspan="1" colspan="1">65.9 &#177; 6.9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4b</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">126.9 &#177; 8.1</td><td align="center" valign="middle" rowspan="1" colspan="1">32.8 &#177; 4.9</td><td align="center" valign="middle" rowspan="1" colspan="1">44.3 &#177; 3.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4c</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.0 &#177; 6.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21.6 &#177; 4.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">62.9 &#177; 6.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cisplatin </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.2 &#177; 4.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16.0 &#177; 3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68.4 &#177; 0.3</td></tr></tbody></table></table-wrap><table-wrap position="float" id="molecules-30-03461-t009" orientation="portrait"><object-id pub-id-type="pii">molecules-30-03461-t009_Table 9</object-id><label>Table 9</label><caption><p>SOD mimetic activity expressed as % of inhibition of radical transfer to INT at concentrations c<sub>1</sub> = 0.572 mM or c<sub>1</sub>* = 0.286 mM for <bold>4b</bold> and c<sub>2</sub> = 0.143 mM and IC<sub>50</sub> values.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity at c<sub>1</sub>/c<sub>1</sub>* (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Activity at c<sub>2</sub> (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SOD-IC<sub>50</sub> (&#956;M)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4a</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">95.8 &#177; 2.2</td><td align="center" valign="middle" rowspan="1" colspan="1">14.3 &#177; 3.3</td><td align="center" valign="middle" rowspan="1" colspan="1">242 &#177; 1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>4b</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">40.1 &#177; 1.9 *</td><td align="center" valign="middle" rowspan="1" colspan="1">35.8 &#177; 1.3</td><td align="center" valign="middle" rowspan="1" colspan="1">1090 &#177; 56</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>4c</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">98.9 &#177; 0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.9 &#177; 1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">189 &#177; 11</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">cystamine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22.1 &#177; 1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.0 &#177; 0.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1700 &#177; 100</td></tr></tbody></table><table-wrap-foot><fn><p>* c<sub>1</sub>* reduced for complex <bold>4b</bold>.</p></fn></table-wrap-foot></table-wrap></sec></back></article></pmc-articleset>